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ABSTRACT 
Field Detection Device of Reactive Oxygen Species 
Danielle Lee Cowgill 
 
Traumatic brain injuries (TBIs) contribute to approximately 30.5% of all 
injury related deaths in the United States per year and approximately 1.7 million 
TBIs per year occur as an isolated injury or other injury. Military personnel are 
exposed to TBIs and have less availability to resources traditionally used to 
diagnose a TBI. Reactive oxygen species (ROS) play a large role in secondary 
traumatic brain damage, especially lipid peroxidation, following TBIs. One of the 
principle and most studied byproducts of lipid peroxidation is malondialdehyde 
(MDA). The focus of this paper was to create an initial proof-of-concept field 
diagnostic device to detect ROS, or constituents, following a TBI. The device was 
divided into three main sections: blood separation, sample separation, and 
detection. This thesis report examined the blood and sample separation sections of 
the device; however the blood separation was not developed due to university 
restrictions. Pre-fabricated microfluidic chips and a confocal microscope were 
used for the separation. Pressure was first used to drive the fluid through the 
channel to observe functionality of the chip with 10 um microspheres and then a 
MDA solution once the spheres were successful. When fluid successfully flowed 
through the channels with pressure, voltage was then applied to the channels to 
create a capillary electrophoresis (CE) system. The CE system was tested with the 
spheres first and then the MDA solution upon successful demonstration of 
voltage-driven flow. Analysis of the images was performed using ImageJ 
software in attempt to determine the velocity of the spheres and MDA. The results 
of the system appeared to successfully drive the MDA with voltage-driven flow 
after waiting for the residual effects of the applied pressure to reduce. However, 
any conclusions require more experimental data. 
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Introduction 
Traumatic brain injuries (TBI) are a common injury especially in combat 
situations. Military personnel are exposed to all three types of TBI including 
closed head TBI, penetrating TBI, and 1st degree explosive blast TBI (Figure 1) 
[30].   
 
Figure 1. Flow chart of factors that are associated with the three main types of 
battlefield traumatic brain injuries [30]. 
It is impossible to prevent all TBIs so diagnosis and treatments are 
incredibly important to maintain quality of life for patients. With the war in Iraq, 
it is predicted that 15.2 to 22.8% of retuning service members will have a TBI 
[30]. Explosive blasts including improvised explosive devices (IEDs) are the 
predominant cause of combat related TBIs [30]. Protective equipment including 
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helmets and body armor shield victims from some injuries like penetrating chest 
or abdomen wounds that would have been fatal [30]. However the lacking 
development with helmets has left the sides and face of military personnel 
exposed and vulnerable to serious injury [30]. By protecting more of the body, 
patients who previously perished due to other injuries are now surviving and 
suffering from TBIs that are sustained from the lack of protection to the cranium 
[30]. Currently, those injured in combat have procedures to aid in the diagnosis of 
severity of damage with verbal questions; however, the open-ended nature of the 
test can miss injuries that progressively deteriorate or do not test the area of the 
brain that is wounded. To fill this void in diagnosis, a system to analyze the 
physiological conditions of the patient needs to be developed. 
Lab-on-a-chip is a current buzzword being used to describe devices that are in 
development for point-of-care diagnostics around the world. The military is in 
need of these types of devices as portability and ease of use are major design 
considerations leaving endless possibilities for such systems. A great application 
for one of these systems would be diagnosing TBIs in the field. There are many 
challenging aspects that arise with the creation of such devices. Many of these 
diagnostic tests require the use of raw biological samples to be processed. One of 
the most common samples is whole blood drawn from a patient. However, most 
tests require the whole blood to be separated to use the blood plasma. 
Additionally, the required information for many of the diseased states, like TBI, 
	   	  	   	  3 
are lacking due to the numerous unknown factors of the pathophysiology and no 
standard protocol for testing for specific biomarkers.  
 One biomarker in assessment for TBI is malondialdehyde (MDA) [13]. It 
is one of the most studied reactive oxygen species (ROS) and is believed to be 
one of the contributing factors to neural tissue damage following TBI [13]. Many 
researchers have hypothesized that there is a correlation between MDA levels in 
human plasma and outcome following TBI [24, 25, 26, 27]. Many variables, like 
detection methodology and plasma treatments, have given rise to the many 
discrepancies in the relationship between TBI and MDA levels.  
 The focus of this paper is to create an initial proof-of-concept field 
diagnostic device to detect ROS, or constituents, following a TBI. Development 
of this device could help determine a relationship between MDA levels following 
TBI over various time points and in relation to the patient’s outcome. The 
information gained by understanding the pathways and relationships, could 
greatly improve future treatment plans in the field of TBI for both military and 
civilians.  
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Background 
Traumatic Brain Injuries  
 Traumatic brain injuries (TBIs) contribute to approximately 30.5% 
of all injury related deaths in the United States per year [1]. Approximately 108 to 
332 new cases per 100,000 people in the global population per year are 
hospitalized due to TBIs [2]. Early detection of TBIs, including point-of-care 
diagnostic tools, may help reduce unfavorable outcomes. Oxidative stress, an 
imbalance in the body resulting in an increase in oxidants over antioxidants, can 
be triggered by a TBI and can lead to secondary brain damage. Biomarkers such 
as reactive oxygen species may be used to determine the severity of TBI, assist in 
determining the best treatment plan for each patient, and help in developing new 
treatments for TBI.   
There are approximately 1.7 million TBIs per year that occur as an 
isolated injury or other injury [1]. Globally, 39% of patients with a severe TBI die 
from the injury, and 60% have an unfavorable outcome based on the Glasgow 
Outcome Scale [5]. The Glasgow Outcome Scale is used to objectively classify 
patients into the following five categories: dead, vegetative, severely disabled, 
moderately disabled, and good recovery [8]. By providing a more accurate 
diagnostic test, physicians can work to improve care for patients with unfavorable 
outcomes. Patients with unfavorable outcomes may have physical alterations in 
the brain can lead to functional short and long-term changes including thinking, 
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sensation, language, and emotion [1]. It also leads to an increased risk of epilepsy, 
conditions like Alzheimer’s and Parkinson’s, and other brain disorders [1]. 
Survivors face prolonged care and rehabilitation including physical, cognitive, 
and psychological and generally die 2 to 3 times faster than the general public [5].  
Improving diagnosis and treatments of TBI not only increases the quality 
of life for patients but also has strong economic benefits. Many relate TBIs with 
military applications such as falls or bodily collisions with objects following 
explosive blasts, penetrating wounds, and severe blows to the head with shrapnel 
or debris [3]. These events often lead to post-traumatic stress disorder (PTSD) 
that can be detrimental to patients. Civilians, particularly older adults, young 
children, and adolescent males, also have TBIs usually caused by falls, vehicle-
related collisions, violence, and sports injuries [3].  In the 2000, the United States 
spent an estimated $76.5 billion due to direct costs, such as medical bills, and 
indirect costs, such as lost productivity of work, of TBIs. A conservative 2007 
report in the United States estimated $396,331 of lifetime costs following 
moderate to severe TBIs with the majority, $330,827, due to disability and lost 
productivity at work and the rest, $65,504, for medical care and rehabilitation [5].   
 The Center for Disease Control and Prevention (CDC) defines a traumatic 
brain injury (TBI) as a “bump, blow or jolt to the head, or penetrating head injury 
that disrupts the normal functions of the brain” [1]. TBIs can cause temporary 
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dysfunction of brain cells leading to a range in severity of TBI from mild to 
severe [3]. In a mild TBI, there is a brief change in mental status or consciousness 
[1]; while a severe TBI is classified as an extended period of unconsciousness or 
amnesia after the injury [1] which can result in bruising, torn tissues, bleeding, 
and other physical damage to the brain that can result in long-term complications 
or death [3].  
Mild TBIs are usually caused by concussions or alterations in brain 
function following a blow to the head [4]. Even though concussions are usually 
mild and brief, they can be damaging, and multiple concussions over time have 
been shown to lead to severe damage [4]. A more serious concussion, or 
contusion, can cause bruising of the brain and permanent neurological damage 
[4]. Severe TBIs often lead to subdural or subarachnoid hemorrhaging, bleeding 
from ruptured vessels following a blow to the head [4]. The blood that 
accumulates in the skull increases intracranial pressure leading to compression of 
the brain tissue, often resulting in death [4].  
Pathologists have determined a simplified pathophysiological molecular 
pathway (Figure 2) to describe the cascade that follows a TBI [5]. The primary 
injury, such as a bomb blast, leads to an increase in concentration of extracellular 
glutamate that binds to neuronal receptors [5]. In turn there is an increase in 
intracellular calcium and sodium ion concentrations and an increase in 
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concentration of extracellular potassium ions [5]. Due to these increased 
concentrations, the cell membrane of the neuron depolarizes and forces the 
mitochondria to malfunction and release reactive oxygen species (ROS) [5]. 
Rising levels of ROS disrupt the body’s homeostasis resulting in oxidative stress, 
which damages the cell membrane, lipids, proteins, and DNA and ultimately leads 
to neuronal death [5]. Understanding pathways like this can lead to improved 
diagnostic techniques and treatments by targeting byproducts of TBI [5].  
 
Figure 2. Simplified pathway describing production of ROS in a neuron [5]. 
 Upon arrival to a trauma center, extensive TBI diagnosis is usually 
determined by imaging techniques, the Glasgow Coma Scale, and intracranial 
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pressure monitoring [3]. The Glasgow Coma scale is an objective 15-point scale 
used to measure the motor response, verbal response, and eye opening response to 
help in determining the level for survival [8]. Imaging includes computed 
tomography (CT) scans that use x-rays and magnetic resonance imaging (MRI) 
that use radio and magnetic rays [3]. The CT scans are to locate any visual regions 
of bleeding, clots, bruises, or swelling of the brain tissue [3]. MRI scans are used 
to produce detailed images in order to locate the prior named injuries [3]. In 
emergency situations, MRIs are not used, as they take longer to perform than that 
of CT scans, therefore they are often used in continuous monitoring of stabilized 
patients [3]. Intracranial monitoring is an invasive procedure in which probes are 
inserted into the skull to observe any swelling of the brain tissue that causes more 
damage to the brain [3]. All of these techniques require highly trained 
professionals and, in the case of the imaging, expensive and time consuming 
leading to more time for the secondary effects to cause more damage to the brain. 
In addition, TBIs have not been thoroughly studied as patients often have other 
life-threatening injuries that need to be treated before TBIs are considered or 
observed. Once a thorough diagnosis has been performed, the treatment plan is 
devised based on the results. 
Current treatments are broken up into pre-hospital, non-surgical, surgical, 
and pharmalogical techniques. Pre-hospital treatments include inserting a flexible 
tube into the airway to aid the patient in breathing [5]. Currently there is no 
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definitive data that demonstrates any positive pre-hospital treatments leaving 
room for research [5]. Non-surgical treatments include therapeutically induced 
hypothermia that can lead to a reduction in the formation of free radicals [5]. 
Results from patients who have undergone therapeutic hypothermia are 
conflicting with dependency on the time the patient undergoes hypothermia, the 
duration the patient is in a hypothermic state, the temperature at which the body is 
in a hypothermic state, and the rate at which the patient is returned to normal body 
temperature [5]. Additionally, there are many side effects to inducing 
hypothermia including clotting problems, increased chances of infection, insulin 
resistance, and cardiac rhythm problems [5]. Surgical treatments include 
decompressive crainectomy and implantation of stem cells [5]. Decompressive 
craniectomy is a surgical technique, where segments of the skull are removed in 
order to decrease intracranial pressure [5]. The procedure is standard for military 
blast injuries to the brain but there are many complications that frequently arise 
including excessive bleeding and cerebrospinal fluid buildup [5]. Stem cell 
transplantation is an experimental procedure in which cells are injected into the 
body via the blood stream to replace neural cells and decrease inflammation [5]. 
There are many difficulties with the procedure including timing of implantation 
and a procedure to directly inject the cells into the injured location without 
causing further damage [5]. Pharmacological techniques include 
immunosuppressive drugs, which stabilize the mitochondrial failure in the neuron, 
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therefore reducing oxidative stress and lipid peroxidation in animal studies [5]. 
Many other drugs have similar concerns with positive results shown in animal 
studies but negative or no results shown in human studies [5]. There are some 
promising pharmaceutical treatments that are undergoing clinical trials to 
determine effectiveness [5]. All of these treatments show progress into creating 
successful results for patients however as seen from the negative results and many 
side effects, there are many avenues to pursue in treatment development for 
patients with TBI.  
Military patients with TBI go through a diagnostic procedure called 
MACE (Military Acute Concussion Evaluation) [28]. MACE is designed to 
evaluate a patient who has received a concussion and determines their current 
clinical status, similar to the Glasgow Coma Scale used in civilian hospitals [28]. 
The 8-page evaluation has specific questions and directions in order to analyze the 
patient’s orientation, immediate memory, neurological screening, concentration, 
and memory recall [28]. Answers are associated with a point scale that can 
demonstrate if a patient has received a concussion but is not a definitive guideline 
for diagnosis [28]. Certain questions are significant indicators for further 
evaluation and the answers can be used to show numerical data for assessment of 
the patient as they are improving in treatments [28]. Once a patient is evaluated 
based on MACE, the appropriate actions are taken either by allowing the patient 
to return to their military duties or to continue with a further diagnosis [28]. While 
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the military uses civilian doctors to help develop processes that best fit the 
situation, they still have significant room for improvement as TBIs have been 
directly related to PTSD and other mental disorders along with death following 
the trauma. Field tests of physiological attributes could greatly aid in the 
diagnosis of TBIs for military personnel especially in combat areas. 
In combat areas, patients are evaluated with the MACE procedure and are 
taken to concussion restoration centers at the military base [28]. However, many 
patients are injured during combat operations, which take place far from the 
military base [28]. When the patient is injured, their buddy asks them the 
questions following the MACE procedure and determines if further care is needed 
or if they can continue without further intervention [28]. If more evaluation is 
deemed necessary, the patient is returned to the base and taken to the concussion 
restoration center [28]. While this process is very successful for patients with mild 
concussions, patients with more severe cases require more complex diagnosis 
such as CT scans which usually are found at hospitals as the machines are large 
and expensive [28]. In the time required to take a patient to the hospital, further 
damage can occur to the brain before the diagnosis and can alter the outcome of 
the patient [28]. Patients often do not show any signs of injury and are not treated 
until their condition is more severe which can be difficult to treat [28]. With the 
key to treatment being early diagnosis, a field test system can improve outcomes 
of patients.  
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Reactive Oxygen Species 
  Reactive oxygen species (ROS), or more commonly known as reactive 
molecules and free radicals, are found in the human body [9]. Free radicals have 
an unpaired electron and are very reactive [10]. A few ROS electron structures 
can be seen in Figure 3 below. 
 
Figure 3. Electron structures of some common reactive oxygen species structures 
[10]. 
ROS are generated as a result of normal intracellular metabolism and a 
number of external factors [11]. Many ROS are byproducts of mitochondrial 
electron transport processes that are constantly occurring in the body [9]. The 
body maintains physiological homeostatic oxidation by regulating ROS 
production and maintaining their concentration to a non-damaging level via an 
enzymatic and non-enzymatic antioxidant system [9, 11]. When the body receives 
an injury, the balance between production and removal shifts away from 
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homeostasis and goes toward a pro-oxidative state (Figure 4) [9]. The shift to pro-
oxidative state is caused by an increased production of ROS and a constant rate of 
removal of ROS leading to an increased concentration of ROS in the body [9]. 
Increased levels of ROS can lead to cell death or acceleration in aging and age-
related diseases as a result of random damage to proteins, lipids, and DNA [11]. 
Chronic pro-oxidative state is potentially linked to aging, chronic diseases, and 
cancer [9]. Detection and identification of ROS can be beneficial in order to better 
understand diseases when determining a cure.  
 
Figure 4. Balance required to maintain oxidative homeostasis [9]. 
ROS play a large role in secondary traumatic brain damage following TBI. 
Secondary traumatic brain damage is associated with changes in basic chemical 
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processes in the brain that then produce physical brain damage leading to 
difficulties with recovery [6]. Following TBI, ROS are produced from 
dysfunctional mitochondria as discussed in the pathway found in the previous 
section [6]. This increase in ROS leads to oxidative stress, which in turn can lead 
to oxidative damage to the lipids, also known as lipid peroxidation, and neuronal 
death [6]. The brain requires a high rate of oxygen consumption and it contains a 
high concentration of polyunsaturated fatty acids therefore it is highly susceptible 
to lipid peroxidation [6].   
Lipid peroxidation or oxidative damage to lipids is the process of in which 
ROS take electrons from the lipids in cell membranes, and can ultimately lead to 
significant tissue damage [12]. In the brain, oxidative damage to lipids can alter 
the viscosity and ability of the cell membrane to allow particles to flow in and out 
of the cell leading to extensive tissue damage [6]. The process of lipid 
peroxidation can also produce many secondary products, including aldehydes, 
which cause further oxidative damage [13]. In vivo, ROS can be difficult to 
measure directly due to their short half-life; therefore many techniques measure 
the byproducts of ROS and lipid peroxidation in order to determine their role in 
diseased states such as TBI [6]. 
One of the principle and most studied byproducts of lipid peroxidation is 
malondialdehyde (MDA) [13]. The main source of MDA is the peroxidation of 
polyunsaturated fatty acids with two or more methylene-interrupted double bonds 
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[13]. There are multiple hypotheses of how this occurs in vivo including the 
following two hypotheses. The first hypothesis described by Pryor and Stanley 
[14] predicts that MDA is derived from prostaglandin-like endoperoxides from 
methyl-linoleate during times of stressful conditions (Figure 5A) [13]. Another 
hypothesis described by Esterbauer [15] details a mechanism of successive 
hydroperoxide formations and beta-cleavage of the fatty acid chain to give a 
hydroperoxyaldehyde [13]. MDA is then produced by beta-scission or by reaction 
of the final acrolein radical with a hydroxyl radical (Figure 5B) [13].  
 
Figure 5. Two hypotheses of formation of MDA A) predicting that MDA is 
derived from prostaglandin-like endoperoxides from methyl-linoleate during 
times of stressful conditions and B) MDA is produced by beta-scission or by 
reaction of the final acrolein radical with a hydroxyl radical [13]. 
A B 
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In vivo, MDA can appear in two different forms: free and total MDA. Free 
MDA is unbound to a protein found in plasma or any other biomolecule therefore 
it can be detected without a sample treatment requiring the sample to be 
chemically decomposed in water therefore providing a faster but less accurate 
method [13]. Total MDA is bound to molecules found in the matrix of the sample 
and requires a treatment of the sample in order to chemically separate the MDA 
from other molecules in order to be detected [13]. Examples of such treatments 
include methods using a strong acid or basic sample to pretreat in order to 
separate the bound fraction of MDA to obtain an estimate of the total MDA in the 
sample [13]. Little is known about the pathophysiological significance of either 
form however most methods used to detect MDA are for total MDA 
concentrations due to their high temperatures and acidic conditions during 
analysis [13]. There is a high percentage of variability between studies in baseline 
readings of total MDA levels in a healthy patient and in patients who have a TBI 
possibly due to the sample pretreatment used and/or method of detection. The 
relationship between TBI and systemic MDA levels are still being debated, as it is 
still a new area of research.  
Another new area of research includes how levels of MDA vary with 
respect to time in patients who have TBIs. In a 2005 review article, 10 different 
studies were compared on their analysis of MDA in human plasma or serum in 
patients without any injuries [13]. The average MDA baseline concentration for 
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healthy patients was 1.3795 ± 0.153 µmol/L with an outlier of 13.8 ± 1.32 µmol/L 
[13]. A German study in 2000 compared plasma MDA concentrations over time 
for isolated TBI patients and patients with other major trauma in addition to TBI 
[2]. The study found steady levels of MDA in surviving isolated TBI patients, a 
decrease in MDA levels for the first two hours following injury for the 
nonsurviving isolated TBI patients, and no relationship with patients with other 
major trauma (Figure 6A) [2]. A 2002 Italian study compared blood samples of 
TBI patients over 48 hours and compared the good and poor outcome group levels 
(Figures 6B and 6C) [6]. They concluded that MDA levels significantly increased 
over time in jugular bulb samples and the MDA levels were statistically 
significantly higher in the poor outcome group versus the good outcome group at 
6 and 12 hours post-injury [6].  
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Figure 6. A) Relationship between time and MDA levels in patients with TBI [2]; 
B) MDA levels in jugular and peripheral blood over 48 hours [6], C) MDA levels 
in poor and good outcome groups over 48 hours [6]. 
One way to progress the affiliation between the two would require a 
standard test and a large population study to gain statistically significant results. 
Many researchers have begun attempting to decipher any correlation between 
systemic MDA concentrations, TBI outcomes, and time following injury. Current 
detection methods range from high power liquid chromatography to mass 
spectroscopy to fluorescent light detection [13]. One of the most common 
detection methods of total MDA is based on its derivatization with thiobarbituric 
acid (TBA) to form thiobarbituric acid-reactive substances (TBARSs) that 
fluoresce (Figure 7)[13,16,29]. The level of TBARS fluorescence can be 
correlated to specific concentrations of total MDA concentration in the sample. 
A B 
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Figure 7. Reaction between MDA and TBA to form TBARS and the 
corresponding excitation and emission spectrums [29]. 
A large problem with the TBARS method is its lack of specificity within a sample 
as the TBA can bind to other molecules that may be present in the sample besides 
MDA to form TBARS [16]. New methods of detecting MDA in a sample, 
including capillary electrophoresis, have begun to be used and found to be very 
accurate with high precision [13].  
 Another method of detection includes high powered liquid 
chromatography (HPLC) with a solid-phase extraction technique in which the 
liquid sample is high pressure injected into a column filled with various sized 
particles [32]. The various particles get stuck along the tube in specific places 
forming separate bands in the column which can be used to separate, identify, and 
quantify compounds in a sample in concentrations as low as parts per trillion [32]. 
One large benefit of the HPLC method is it provides a high level of accuracy 
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especially in samples with minimal concentrations of the substance and the 
columns can be repeatedly used [32]. However, HPLC requires equipment that 
cannot be scaled down and the equipment is extremely expensive [32]. Many 
researchers have decided these obstacles are difficult to overcome and are looking 
into developing miniaturized capillary electrophoresis (CE) systems.  
Capillary Electrophoresis 
 Electrophoresis is defied as “the separation of charged species in a fluid 
when subjected to an electric field due to differences in the mobilities of 
individual species which in turn results in differences in the species velocity and 
therefore the distance travelled within a fixed time frame” [21]. In operation, 
induced electric fields, generally 50-250 volts/cm, mobilize ionic species to travel 
through a capillary based on its electrophoretic mobility and the strength of the 
electric field [21]. This technique is used for a variety of applications including 
the analysis of DNA, environmental and water quality metal ion detection, food 
and drink, and corrosion [21].  
Electrophoresis is a type of fluid flow phenomenon in which a charged 
surface plus attached material move relative to stationary liquid by an applied 
electric field [23]. In order for this to occur, the system consists of buffer 
reservoirs, a sample reservoir, a high voltage power supply, electrodes, a 
capillary, and a detection system [22]. In the system, the capillary creates a double 
layer to allow for flow of the sample from the inlet to outlet [21]. Detection 
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systems vary from laser-induced fluorescence to UV detection to electrochemical 
detection [21].  
 Electroosmosis is the movement of a liquid relative to a stationary charged 
surface, usually a capillary, by an applied electric field, such as in electrophoresis 
[23]. In order for this movement to occur, the electric double layer must be 
formed along the walls of the capillary. The electric double layer is an area next to 
the positively charged capillary surface in which ions, or positive and negative 
charged particles, attempt to neutralize the surface [23]. The ions are unable to 
offset the charge of the capillary surface due to the large number of negatively 
opposing ions compared to the positive ions created by the charge on the capillary 
(Figure 8, top)[23]. The positively charged surface of the capillary wall causes the 
negative ions, or anions, in the fluid to be attracted and bind together in order to 
create an inner layer on called the stern layer (Figure 8, top) [21]. More cations, or 
positively charged ions, extend into the middle of the fluid of the capillary in 
order to attempt to offset the charge on the capillary surface and create the mobile 
layer [21]. The value of the difference in the charges of the ions between the 
mobile and stern layers is called the zeta potential [23]. The velocity of the fluid is 
dependent on the strength of the electric field applied to the capillary and the zeta 
potential [23]. The velocity provides a flat flow profile unlike the rounded profile 
found in laminar flow (Figure 8, bottom)[23]. By altering the pH of the solution, 
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the velocity will change depending on its effect on the fluid in relation to the 
applied electric field [21].  
 
Figure 8. (Top) Schematic of the formation of the double layer [23]; (Bottom) 
comparison between parabolic flow caused by pressure differences and flat flow 
caused by capillary electrophoresis [23]. 
Electrophoresis comes in the form of gel and capillary methods where the 
capillary is either a gel slab or a capillary tube. In gel electrophoresis, the 
polyacrylamide or agrose gel acts as both the capillary and buffer [21]. The gel 
contains pores that allow particles to travel through it at various rates [21]. The 
sample is injected into the gel at one end and the positive electrode is placed at the 
other end [21]. When the voltage source is turned on, the voltage travels through 
the gel and causes the particles in the sample to flow towards the electrode at the 
Capillary 
Wall 
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other end [21]. The particle’s velocity through the gel is dependent on the size 
ratio of pore to particle; so small particles can pass through the pores easier than 
that of a larger molecule so their velocity is greater [21]. This process requires a 
physical size difference between the charged molecules found in the sample, and 
can have a long separation time of hours or even days [21].  
 
Figure 8. Basic schematic design of capillary electrophoresis system [21]. 
Capillary electrophoresis (CE) is comprised of two buffer reservoirs, 
positive and negative electrodes, a detector system, data acquisition system, and 
high voltage power source (Figure 9) [21]. The capillary is usually made of fused 
silica with varying inner diameters usually 25 to 100 microns [21]. The same 
principles for CE apply as with gel electrophoresis with the sample at one end, 
and the electrodes at either end [21]. When the voltage is applied, the particles 
found in the sample travel through the capillary at various rates based on their size 
and charge [21]. As the particles pass the detector window, the acquisition system 
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records the type and concentration of particles as they pass by the window [21]. 
CE comes in multiple forms including capillary isoelectric focusing and 
isotachophoresis [21].  
 In capillary isoelectric focusing, usually proteins, are separated by 
adjusting the gradient of the pH of the buffer created in the capillary so the 
desired protein moves along the capillary until it reaches the pH where it is 
electrically neutral [21]. Isotachophoresis uses two different buffer solutions as a 
leading and terminating electrolyte with the sample falling between the two [21]. 
The different mobilities create different electric fields across the different sections 
and will not allow the sample to mix with the two buffers [21]. Unfortunately, the 
technique cannot separate samples containing both anions and cations in a single 
run as the mobilities oppose charges [21]. Currently, bidirectional systems are 
being developed to allow samples with both cations and ions to be separated at the 
same time in the system to reduce analysis time but this requires two separate 
detectors [21]. Each system was developed to detect substances in a variety of 
samples and is continuously being developed to increase efficiency for their 
intended purpose.  
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Figure 9. Table-top CE system used to detect charged molecules found in a 
sample (Cal Poly, Dairy Science Center). 
 Table-top CE systems are fairly common in standard laboratories as they 
provide an automated and fast analysis of a sample (Figure 10). Within the 
system, fused silica capillaries of various inner and outer diameters can be loaded 
into the system based on the sample type and desired outcome. A small window is 
usually etched into the capillary at a defined length away from the sample 
entrance to allow for detection, creating a capillary zone electrophoresis system. 
Multiple samples can be loaded into the system on the sample tray in various vials 
along with a known substance as the control. To begin the system, parameters, 
such as run voltage and time, are input into a directing computer that is attached 
to the machine. Next, the cleaning and run buffers are run through the capillary, 
usually by pressure injection, to prepare the capillary for the samples. The anode 
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electrode is automatically lowered into the sample vial and a voltage is applied to 
draw the solution into the capillary (Figure 11). 
 
Figure 10. Sample end of table-top CE system with capillary and cathode 
electrode extending into vials of samples and buffers on the sample tray (Cal 
Poly, Dairy Science Center). 
 Between samples, the cleaning and run buffers are processed to cleanse the 
system of any remnants from prior samples. The capillary runs through the 
detection system that sends the data to the analysis computer system to be 
recorded. Finally, the capillary ends in the waste platform where the cathode is 
located and the sample waste is discarded (Figure 12). 
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Figure 11. Waste platform of table-top CE system with capillary and anode 
electrode extending into vials for waste (Cal Poly, Dairy Science Center). 
Currently, microchip CE systems are being developed as a form of a 
miniaturized system (Figure 13). Some benefits of a miniaturized capillary system 
include portable monitoring, reduced cost, disposability, reduction in required 
sample volume, faster analysis times, and the easier ability to generate a large 
electric field [21]. When designing a microchip CE system there are a variety of 
design considerations including the size, weight, power lifetime supply, device 
lifetime, self-directed (for sample loading, microfluidic priming and pumping, 
cleaning, and operation and analysis), universal buffering system with minimal to 
no sample preparation, and fast analysis performed on the microchip and 
displayed on the device [21]. Two of the most challenging aspects of developing a 
microchip CE system include the development of a sample injection system and 
the high voltage power supply.  
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Figure 12. Typical layout for microchip CE device [21]. 
 Sample injection systems are used to introduce the sample solution into 
the separation channel (Figure 14a) [21]. Some sample injection systems for a 
microchip design include electrokinetic injection and flow injection (FI). A FI 
system has the sample injected into the separation channel with a pressurized 
pump while the buffer fluid is concurrently flowing in the separation channel 
[21]. A form of FI uses a pinched injection scheme where the electric field 
between the buffer and waste reservoir causes fluid to flow toward the sample 
waste well where it intersects with the separation channel [21]. This allows for an 
accurate, repeatable, and highly efficient separation but requires a very precise 
fluidic control [21]. Electrokinetic injection uses an applied voltage to create an 
electric field between the sample and sample waste well to move the sample 
across the separation channel (Figure 14b) [21]. One the sample reaches the 
intersection, the electrodes in the buffer and waste reservoirs receive voltage and 
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the plug travels down the separation channel (Figure 14c) [21]. This system does 
not require a mechanical system but can cause inaccuracies in readings or sample 
biasing due to variances in the mobility of the sample components. Different 
particles found in the sample leave the sample reservoir at various rates due to the 
applied electric field causing the sample to separate prior to reaching the 
separation channel once mixed with the buffer solution. Another problem that 
occurs during electrokinetic injection is caused by the applied electric field 
changing the pH of the solutions due to electrolysis that potentially can alter the 
behavior of the particle [21]. 
 
Figure 13. Setup and functionality of chip-based electrokinetic injection for CE 
system [21]. 
In order to create these electric fields, a high voltage power supply is 
required. When designing a high voltage power supply, there must be a 
compromise between size, power consumption, and performance [21]. Many 
protocols require voltages in the kilivolt range in order to move the charged 
particles in the sample for any distance in a short period of time [21]. However, 
using microchips allow for lower voltages due to significantly shorter capillary 
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lengths. Still using high voltages require safety precautions to be designed into the 
system including the use of trip switches that turn off the voltage when the case is 
opened [21]. In order to produce high voltages for portable CE systems, 
researchers have optimized the process of using DC-to-DC converters that take a 
low voltage input and convert it to a much higher voltage [21]. Researchers are 
attempting to make chip-based and non-chip-based CE systems for portable 
applications.  
 Some chip-based CE systems include the µChemLab and a device created 
by Becker et al (Figure 13A and B)[21]. The µChemLab is a hand-held CE 
system is a battery powered, ergonomically designed device that weighs less than 
2 kg and uses reusable microfluidic chips [21]. The µChemLab, Becker device, 
and a variety of others use their own high voltage power supplies. One system 
uses piezoelectric transformers due to their high transformation ratio and their 
smaller size and cost when compared to magnetic transformers [21]. The Becker 
system used two couple commercial miniature unipolar power supply modules to 
proved a bipolar driving power supply [21]. All of these devices were journal 
articles that were for detection of specific samples. Biomarkers, including ROS, 
are a large area of research with relation to CE as CE systems provide a strong 
platform for development of lab-on-a-chip systems to be used as point-of-care 
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diagnosis.  
 
Figure 14. Examples of chip-based CE systems including (A) the µChemLab and 
(B) a system created by Becker et al [21].  
 Research into malondialdehyde detection in a sample using CE is 
becoming very popular as many labs have the systems. It can have fairly precise 
and repeatable readings, and it has a short analysis time [21]. Biological samples 
for MDA detection include urine, blood, and breath condensate however the most 
common is human plasma from whole blood [13]. Most articles use plasma from 
healthy individuals, then add MDA salt to the sample and compare the detected 
concentration to the input concentration to determine the accuracy of the process 
[13]. A large benefit of microchip CE systems is their ability to use a minor 
volume of blood sample to produce an accurate representation of concentration in 
the body [21]. Many have found that CE, especially high performance CE, is 
more accurate than the traditional method of fluorimetry [21]. Various parameters 
are used for detection of human plasma MDA including the inner diameter of the 
A B 
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capillary, total and run lengths of the capillary, the run and cleaning buffer 
solutions, and the run voltage (Table 1) [24, 25, 26, 27]. The variation of 
parameters is due to the various models of table top CE machines and preferences 
of the difference laboratories. In addition, the process of detecting MDA with CE 
systems is still being perfected so multiple methods are attempted in order to 
determine the most accurate and repeatable process. The conclusion for all of the 
articles was the high accuracy of detection of free MDA in the sample and the 
strong potential to create a microchip based CE system for point-of-care 
diagnostics for the detection of MDA in oxidative stress situations [24, 25, 26, 
27].  
Table 1. Parameters used in various studies using CE to detect MDA in human 
plasma [24,25,26,27]. 
 
All of the articles that discuss plasma MDA concentrations and its relation to TBI, 
state the lack of information available, and the strong potentials that the 
information could provide. As the relationship between MDA and TBI is slowly 
Article ID of tubing Lngth of tube run buffer run voltage Cleaning buffer
R. Paroni [24] 50 micron
27 cm total
20 cm run
25 mmol/L borax 
5 mmol/L TDTAB
pH 9.3 -4 kV
1 mol/L NaOH
0.1 mol/L NaOH
A. Zinellu [25] 75 micron
60 cm total
50 cm run
300 mmol/L sodium borate
50 mmol/L N-methylglucamine
pH 10.0 25 kV 0.5 mmol/L NaOH
D. Wilson [26] 75 micron 60 cm total
10 mmol/L sodium tetraborate, 
10 mmol/L sodium monosphate, 
100 mL/L acetonitrile
pH 8.0 18 kV
K.N. Korizis [27] 50 micron 56 cm active
20 mM borate 
pH 9.3 30 kV
.01 M NaOH 
DI Water
Run Buffer
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being understood, further research is required in order to fill the lack of 
information in the field of study. A standard method of detection could prove 
invaluable as the concentrations of MDA vary pending on the various techniques 
and variables between the systems. One common and accurate sample types used 
to detect MDA is blood. Unfortunately there are many items found in blood that 
can give false readings and can make detection impossible. In order to get the 
most accurate reading, plasma containing the MDA needs to be separated out of 
the sample.  
Blood Filtration 
 There are multiple types of biomarkers that can be found in the body via a 
variety of biological samples including biopsied tissue, breath condensate, urine, 
saliva, and blood. Blood is frequently used as a biological sample when looking 
for specific biomarkers due to its ease to obtain and its high concentrations of 
certain systemic and circulating molecules such as proteins. MDA is found in a 
variety of biological samples but most researchers use blood due to its ease of 
access unlike more dangerous methods of sample acquirement such as cerebral 
fluid [9]. Additionally, MDA can enter the blood stream via the blood-brain 
barrier and is quickly circulated throughout the body. One large challenge of 
using blood as a biological sample for biomarkers is the required pretreatment 
methods in order to separate out artifacts that could give inaccurate results.  
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 Whole blood is comprised of platelets, white blood cells, red blood cells, 
and plasma each ranging in size (Table 2). White blood cells (WBCs), or 
leukocytes, come in a variety of shapes and sizes consisting of neutrophils, 
monocytes, macrophages, and lymphocytes which are responsible for the immune 
system in the body [17]. Platelets or thrombocytes are irregularly shaped 
fragments of cells that circulate in the blood to be activated in the formation of a 
blood clot [17]. Red blood cells, or erythrocytes, are the most common type of 
cell in blood, most dense substance in blood, and have a biconcave shape to allow 
for a greater surface area to transport oxygen throughout the body [17]. Plasma is 
the straw colored fluid comprising approximately 60% of blood consisting mainly 
of water with some proteins, antibodies, hormones, sugars, and fat particles [17]. 
When looking for biomarkers, most bioseparation tests require plasma therefore 
the other components must be separated from whole blood prior to the test.  
 
Table 2. Sizes of components found in whole blood [17]. 
Blood Component Diameter (microns) 
White Blood Cells 7-15 
Platelets 2-4 
Red Blood Cells 6-8 
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In order to stabilize the blood during the withdraw process, additives such 
as anticoagulants are used as pretreatment techniques to help separate blood 
components from the plasma [18]. However, some of these anticoagulants can 
have a strong influence on results from the sample [13]. When determining MDA 
concentrations in the body, researchers have determined that different 
anticoagulants have a strong influence on plasma MDA concentrations [13]. For 
example, plasma treated with EDTA showed lower concentrations when 
compared to citrate treated samples due to the fact that citrate does not bind to 
trace metals or calcium ions in the blood therefore preventing more MDA 
production after the blood has been drawn [13]. This observation that the use of 
anticoagulants during pretreatment could explain the variances in MDA values 
[13].  
 When preparing the sample, a variety of filtration methods have been used 
including centrifugation, membrane filters, and microfluidic chips. Centrifugation 
is the most common method for separating whole blood into plasma however it 
cannot be utilized for point-of-care diagnostic devices. Membrane filters such as 
the Vivid™ and Accuwik™ Plasma Separation Membranes have been developed 
to replace centrifugation to obtain plasma for biological testing [19]. These 
membranes have an asymmetric shape that catches cells in large pores on one side 
and allows the plasma to pass through the smaller pores to produce a sample 
comparable to that of one that has processed through centrifugation [19].  
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Recently microfluidic chips have been designed and optimized with the 
potential to be integrated with another chip-based bioseparation analysis 
technique [20]. Electrical fields have been shown to separate particles and cells 
out of solutions, which makes it an excellent method to apply to chip-based 
technologies. In a study by Jiang and associates, electric fields were applied to 
move cells and particles in various directions based on size and strength of the 
applied electric field [20]. Electro-osmotic flow moves items with weaker 
electrostatic charge such as liquids [20]. Electrophoresis of cells and particles is 
due to electroosmosis movement from stronger electric fields [20]. The main 
channel on the chip transports the bulk solution with a strong electric field while 
weaker electric fields move across the branching channels to separate the liquid 
out into the branches [20]. Branching channels are narrower than the main 
channel that prevents cells and particles from entering [20]. Additionally, the 
electro-osmotic flow that is created by the field moves the plasma from the bulk 
into the branching channels [20]. 
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Figure 15. Diagram of an example microchip design used to separate whole blood 
in Jiang experiment [20]. 
The chip from the Jiang experiment consists of four wells, a main micro 
channel, five branching channels, an assistant channel, a neck channel, and four 
electrodes (Figure 15) [20]. The wells or reservoirs were filled with the buffer 
solution and well A also contained the sample [20]. The main micro channel ran 
between reservoirs A and B and provided the location for movement of the bulk 
solution [20]. The assistant channel runs between wells C and D and moves 
separated plasma from the neck channel to well D [20]. The five branches 
between the main and assistant channels are the location for the separation of 
plasma out of the bulk solution [20]. The neck channel connects the branch 
channels and the assistant channel [20]. Finally, the four platinum electrodes are 
placed in each well and control the applied electric field by supplying voltage to 
the system [20]. 
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Fabrication of the chips utilized a soft lithography process for creating the 
master chip and molding for the test chips [20]. The master process consisted of 
spin coating a negative photoresist onto a silicon wafer that was then pre-baked 
[20]. Next, the wafer was exposed to a mask pattern using UV light and then post-
baked [20]. Finally, the chip was developed with the locations of the various 
channels [20]. Test chips were then made with a degased polydimethylsiloxane 
(PDMS) solution combined with a curing agent [20]. Once cured, the chips were 
peeled off the master wafer, holes for reservoirs were then punched out, and the 
chip was bonded with a glass slide to create the channels [20].  
At the conclusion of the study, it was determined that the system was 
successful in providing a proof-of-concept device that provided a method for 
separating blood and plasma using electro-osmotic forces [20]. The developed 
method was able to keep almost 100% of the cells out of the branch channels by 
optimizing the voltages leading to a controlled applied electric field to move the 
cells and liquid [20]. The benefits of this system include its lack of requirement 
for complex microfabrication techniques and absence of external pumping 
devices [20]. It is very possible to use this technology and process in a point-of-
care diagnostic device in the near future. Other future work includes more 
research into using the separated plasma for further analysis. The next step will be 
to develop other testing processes on a chip that can be integrated with this 
procedure. Early detection of MDA in a point-of-care diagnostic CE microchip 
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device may help to provide a better level of care for patients and to help develop 
techniques and pharmaceudicals to reduce oxidative stress damage to neural 
tissues. 
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Design Process 
Introduction 
 The goal of this thesis project was to design a proof-of-concept field 
system in order to detect reactive oxygen species in the body that are released 
following a traumatic brain injury. In order to meet the goals of the device, the 
following general requirements were determined for the final device: fueled by 
own energy source (cannot plug into electrical outlet), cannot rely on any other 
power-operated machines (no centrifuge machine), and suitable in size and 
durability to be carried with a field medic. These design requirements were vague 
as research determined from this proof-of-concept would help develop more 
defined requirements for later prototypes. In order to accomplish this task, the 
device was divided into three main sections: blood separation, sample separation, 
and detection. This thesis report will examine the blood and sample separation 
sections of the device. The following section discusses the design process used for 
determining the blood separation technique and developing the proof-of-concept 
sample separation device.  
Designs 
Blood Separation 
The first portion of the system requires whole blood to be separated into 
plasma and other constituents prior to being injected into the device. The blood 
filtration portion must meet the same requirements as the entire device, and must 
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be compatible with the sample separation portion of the device. The three options 
considered included centrifugation, membrane filters, and a microfluidic chip.  
The separation technique would need to be able to be implemented into a 
point-of-care diagnostic device, therefore traditional centrifugation techniques 
would not be appropriate for the application as they require electricity to run the 
preexisting machines. The membrane filters, such as the VividTM and AccuwikTM 
Plasma separation membranes, previously discussed in the blood separation 
section, are better suited to the field aspect of the requirements. Unfortunately, the 
membrane comes in sheets that would require building an additional contraption 
to hold the membrane. The additional blood filtration unit would be used to filter 
the blood after being drawn from the patient. The plasma that would be separated 
out would then be injected into the sample separation designs.  
Recreating the microfluidic chip study (discussed in the previous section) 
would be ideal for this application as it could be integrated into a complete 
system. The blood could be injected into the blood separation design, where it 
would separate into plasma and then flow into the CE separation system for 
analysis. Essentially, the system would require the user to inject whole blood into 
the blood separation channel and the system would then separate and analyze the 
MDA from the plasma. 
California Polytechnic State University, San Luis Obispo requires any data 
collected from tissue samples from human subjects must have the approval of 
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Human Subjects Committee (HSC) prior to data collection. The review of the 
application for the desired study of the proposed protocol could take anywhere 
from 3 weeks to over 2 months. Due to the confidentiality and timeline of the 
project, it was not feasible to perform these tests.   
Sample Separation 
 Initial Designs 
 The next aspect of the device considered was the sample separation 
design. The same design aspects were considered when selecting the final design 
of the sample separation. Three techniques were considered when selecting the 
design to continue forward with developing: fluorescent dyes, liquid 
chromatography, and capillary electrophoresis.  
 Fluorescent dyes can be used to identify particles in a sample by multiple 
methods including binding to the desired subject and emitting fluorescent light 
[37]. Advantages of this method include the ability to detect low abundant and 
sub-resolution molecules and it is well understood [37]. Disadvantages of 
fluorescence include its complexity of the procedure as it can require long 
incubation times with specific high temperatures in order for the dyes to correctly 
initiate [37]. In addition, fluorescent dyes used to detect MDA in samples can 
produce artifacts, or inaccurate anomalies, that can provide false results [37].  
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 High performance liquid chromatography (HPLC) detects particles and 
their concentrations by running the sample, dissolved in a known solution, 
through a tube with stationary particles to inhibit the flow of some particles and 
allow others including the desired specimen to pass through to be detected. The 
advantages of HPLC include high accuracy of detection and short separation 
times (5-25 minutes) [32]. Shortcomings of HPLC include its high cost of the 
columns, between $475 and $750 based on the desired size [33]. In addition, 
feasibility of miniaturizing a HPLC system was determined to be difficult as 
published work on the feat was lacking when compared to information found on 
shrinking a capillary electrophoresis (CE) systems.   
CE systems use high voltages to separate charged particles in medium in 
order to separate and detect concentrations of desired items in a sample. Some 
advantages of CE include its fast separation time, minimum requires sample 
volume, and significant amount of available information especially with regard to 
miniaturization and detection of MDA [21]. Some disadvantages of CE include its 
high voltage requirement and the dangers associated with using high voltages.  
After comparing the three systems with regard to the positive and negative 
arguments, it was determined that capillary electrophoresis was the best option to 
meet the requirements specified by the sponsor especially due to its feasibility. 
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After viewing the table-top CE system from Cal Poly’s Dairy Science Center, 
multiple designs for CE systems were brainstormed. 
One design for the CE system was a single use cartridge (Figure 16) that 
would be inserted into a reusable CE system. The cartridge would contain a 
specific volume of buffer that would mix with the sample that would be injected 
from a syringe. The system would consist of electrodes, a vacuum, and a detection 
system that could be reused as the samples would never make direct contact or 
cause contamination of any parts. However, the cost of replacing the fused silica 
capillary would not be cost effective as they cost approximately $10 per meter 
and the lengths necessary could be too long for a field device [34].  
 
 
Figure 16. Sketch of a brainstormed idea of a CE system using single-use 
cartridges. 
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Another CE system concept that was considered was a basic miniaturized 
system. The fused silica capillary would be cleaned between samples and 
therefore could be used for a maximum of 400 runs if properly cleaned and stored 
[31]. One system consisted of a series of tanks and valves in which the plasma is 
separated from the blood then released into the mixing tank via a valve where it 
mixes with the buffer solution (Figure 17). The vacuum would pull the sample 
into the capillary where the voltage would be applied to the electrodes and move 
the desired MDA down the capillary toward the window and UV detection 
system, and finally ending in the waste tank (Figure 17).   
 
Figure 17. Drawing of a brainstorm of a simplified CE system design consisting 
of various valves and tanks. 
 
Another simple CE model consisted of two wells, a capillary, electrodes, 
vacuum, detection system, and power source contained in a simple housing 
container was designed as a bench top model (Figure 18). The sample would be 
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filtered and combined with the buffer externally, then pipetted into the cuvette on 
the left in the figure (Figure 18). Next, the vacuum would pull the sample into the 
capillary where voltage would be applied to the electrodes and the MDA would 
flow to the detector and finally end in the second cuvette as waste. 
 
Figure 18. Drawing of a brainstorm of a simplified CE system design with an 
external blood separation system housed in a simple housing container. 
After comparing the various brainstormed ideas, a basic, scaled-down CE system 
was then determined to be the best method to proceed forward as it met all the 
design requirements and appeared to be the most feasible. While looking for 
supplies and reading articles to learn more about miniaturizing CE systems, 
purchasing a pre-fabricated microfluidic chip was considered. The chip could 
provide wells for the sample and buffer solutions, various shaped capillaries, and 
it is all self-contained therefore it would fulfill the need for a housing container, 
wells, and capillary. As the capillary length could be significantly shorter than 
typical tabletop systems, voltage could be decreased and separation times would 
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still be in minutes with the ability to view the moving solution at any portion 
along the capillary by using a microscope. In addition, the chip can be cleaned 
after each run and could be used for a maximum of 400 runs if properly cleaned 
and stored [21]. 
Microfluidic chips can be fabricated with any desired design however, 
more complex designs cause the price to increase if it is not an off the shelf 
layout. Due to the particles moving based on their charge attraction down the 
capillary, chip design was considered based on cost and simple geometry in order 
to make cleaning the capillary easier. After company research, the cross-channel 
layout was determined to be the most cost-effective and met the needs for a CE 
system.  
 The chosen and purchased chips were three pre-fabricated microfluidic 
chips of 2 inches long by 1 inch wide [35], which had a cross-channel design with 
four reservoirs (buffer, sample, buffer waste, and sample waste), an injection 
channel, and a separation channel (Figure 19) [35]. The channel dimensions were 
100 µm wide by 100 µm deep, and the separation channel was 28.0 mm long [35]. 
The dimensions for the rest of the chip were two 7.0 mm long sample channels, 
the 10.0 mm long sample channel, the 1.0 mm diameter access holes, and the 
thickness of the top and bottom of the chip, which varies, based on orientation of 
the chip (Figure 19) [35].  
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Figure 19. Drawing of the pre-fabricated microfluidic chips purchased from 
Translume [35]. 
 
Two of the chips were bottom-up orientation, meaning the bottom of the 
chip is thinner than the top to use on an inverted microscope, with a base of 0.17 
mm height, that was used for the confocal microscope [35]. The last chip was a 
top-down orientation, with a base height of 1.0 mm, that was used for table-top 
microscope applications [35]. On the top of the chip, female luer lock connectors 
were mounted to connect with male luer lock connectors and to make sample 
placement into the wells easier (Figure 20). Loose compatible barbed male luer 
connectors were also purchased from the same company for attachment of other 
supplies to the microchip. Table 3 lists all products from Translume and their 
associated costs.  
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Figure 20. Chip with attached female luer lock connectors [35]. 
 
Table 3. Cost of Products from Translume [35]. 
Item Quantity Unit Price 
Bottom-Up Chip 2 $202 
Top-Down Chip 1 $302 
Luer Connectors 2 $25 
 Total Cost $756 
 
 Final Design of Proof of Concept 
The final proof-of-concept design consisted of the separation portion of 
the system. The prototype consists of a microfluidic chip, two luer connector 
caps, two male-female luer lock connectors, two female-female connectors, two 
female T-shaped luer connectors, two bare wired electrodes attached to two male 
luer connectors, and a luer connector syringe (Figure 21 and Table 4).  
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Figure 21. Prototype with main components labeled. 
 
Table 4. Table of labeled items found on Figure 21 of prototype. 
Number on Image Component 
1 Bare Wired Electrodes 
2 Male Luer Connectors 
3 T-Shaped Luer Connectors 
4 Female-Female Connectors 
5 Luer Connector Caps 
6 Luer Connector Syringe 
7 Male-Female Luer Lock Connectors 
8 Microfluidic Chip 
 
 
To build the device, two wells on the microfluidic chip were capped in 
order to only allow flow through the separation and sample channel. The two 
capped wells are provided for later development of the device. Next, the male-
female luer lock connectors were attached to the luer connectors found on the 
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sample and waste wells of the chip. Then the female-female connectors were 
attached to the chip on one end and the t-shaped connector on the other. Finally, 
the t-connector had one end had the bare wire electrode heat wrap attached with a 
luer connector, and the sample end had a filled syringe while the waste end was 
open to the air (Figure 21).  
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Methods and Results 
The following section discusses the experiments that were performed in order 
to demonstrate the feasibility of the capillary electrophoresis microfluidic chip to 
detect malondildehyde which has been linked to traumatic brain injuries. The 
series of experiments was designed to validate portions of the system in order to 
pinpoint any potential problems that could arise. First, the chip was tested with 
pressure driven flow of microspheres in order to confirm accurate fluid flow 
through the 100 µm wide by 100 µm deep channels. Next, the chip was tested 
with pressure driven flow of MDA solution in order to verify that it would flow 
through the channels and pressure driven flow could be used if voltage driven 
flow failed. Then, voltage was applied to the microsphere solution in a chip in 
order to learn how to set up a CE system. Finally, the MDA was used in place of 
the microsphere solution in order to validate the proof-of-concept for a potential 
field device to determine if it is feasible to continue. 
Pressure Driven Flow on Confocal Microscope 
Microspheres 
 The first test flowed fluorescent microspheres through the microfluidic 
chip to ensure proper flow and to practice the microchip set up on a confocal 
microscope. Two barbed male luer connectors were attached to the buffer and 
buffer waste reservoirs, and 1/8” inner diameter tubing was connected to the 
barbed end of both of the male luer connectors (Figure 22).  
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Figure 22. Pressure-driven system used to validate microfluidic chip on confocal 
microscope. 
 
 
Deionized water was flushed through the channels to clear them using a syringe 
connected to the end of the tube leading from the buffer reservoir. The connection 
between the syringe and tubing required the use of a female to female connector 
and a barbed male luer connector. The sample reservoirs were capped with plugs 
to prevent any fluid from flowing out of the reservoirs.  
Following the deionized flush, the microspheres were loaded into the 
microchip. A solution of 9.9 µm-diameter fluorescent polystyrene microspheres 
(Life Technologies) was created by combining 100 µL of spheres with 5 mL of 
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deionized water in a 50 mL conical tube then sonicated for 2 minutes in tap water 
to separate the particles. The solution was then drawn into a syringe and attached 
to the system previously described. The system was set up on a table with an 
Olympus Fluoview Laser Scanning Confocal Microscope (FV1000, Olympus 
America, Centerville, PA) and then placed in the sample holder of the 
microscope. The 20x objective was used for observing and imaging the microchip 
with microspheres. The 100 µm wide by 100 µm deep separation channel was 
found using the brightfield setting and focus was adjusted using the coarse and 
fine focusing knobs to clearly define the channel at an arbitrary location. Once the 
channel was clearly defined, the light source was changed to widefield 
fluorescence with a mercury arc lamp in order to get a two-dimensional image to 
see the spheres. A micropipette tip box was used to hold the syringe in a more 
vertical position in order to balance the weight and keep the microchip on the 
stage. Once the system was set up, the channel was highlighted for the field of 
vies to ease in viewing the movement of the microspheres. Next, slight pressure 
was applied to the syringe by hand while concurrently viewing the channel to 
determine when to stop applying pressure. Once the green fluorescent 
microspheres appeared in the field of view, pressure was released and images 
were taken.  
Using the FluoView software (Olympus America, Centerville, PA) on the 
corresponding computer, the microspheres were imaged a single-plane at a time. 
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The images were taken by scanning a laser across the sample on a single plane 
over time with a scan rate of 2 µsec/frame. After the desired time, scanning ended 
and the image files were defaultly saved as .oib file types and then exported as .tif 
files to process later. The .oib file type is the standard Olympus format and is 
necessary to save all information related to the microscope settings. The files need 
to be in .tif format for processing in the desired program, ImageJ.  
 Next, the concentration of microspheres was increased to make it easier to 
view the microspheres and to see if they would alter the flow through the 
channels. In order to have a more microspheres in the field of view for a larger 
sample size, 500 µL more microspheres were added to the remaining solution of 
approximately 3mL of the prior solution in order to determine functionality of 
flow through the chip. The syringe was again attached to the system and images 
were taken. The increased concentration solution had the desired result with more 
microspheres appearing in the field of view. Desired images were then taken as 
.oib files then exported as .tif for processing using the same procedure as 
described previously. After testing, the channels were flushed using a syringe and 
deionized water. When performing both tests, the microchip would not stay on the 
confocal microscope stage so a new holding fixture was created.  
 A microchip fixture was created in order make the microchip into the 
same dimensions as a standard glass microscope slide to hold the microchip onto 
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the confocal stage. AutoCAD was used to create two different components that 
would sandwich the microchip and hold it in place. The top piece (top left portion 
of Figure 23) fit around the chip and held the chip onto the bottom portion (top 
right side of Figure 23). The bottom portion contained a smaller hole that focused 
on the separation channel to allow for direct access for viewing on the confocal 
microscope. First, ¼ inch thick acrylic (McMaster Carr) was used but found to be 
too thick to see the channel when placed on the stage of the confocal microscope. 
Next, 3/32 inch thick acrylic was used and again found to be too thick when 
placed on the confocal microscope. Finally, 5/64 inch thick acrylic was used and 
was able to see the channel when positioned onto the confocal. Each time, the 
CAD file was loaded onto the desktop of the laptop in the IME Machine Shop 
(Building 41, Cal Poly) and cut using the laser cutter with the help of Mr. David 
Laiho (bottom of Figure 23).  
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Figure 23. (Top) AutoCAD drawing of chip holder used to cut the acrylic. 
(Bottom) Completed chip holding fixture with lip to hold chip while fixture is 
held by stage of confocal microscope. 
 
ImageJ Results & Analysis 
In order to obtain data from the images, all images were analyzed using 
ImageJ, a Java-based image processing program developed at the NIH used for 
biological image analysis [32]. The files were opened in the program and 
appeared as multiple images over time, called a stack. The stacks were made up of 
2 channels, differential interference contrast (DIC) and fluorescent. DIC 
microscopy uses prisms to manipulate polarized light to increase contrast in 
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samples. The channels were then separated in the stack in order to analyze the two 
channels independently as the spheres may look differently in the channels. To 
separate the channels and frames, substacks were created (Image èStacks èTools 
èMake Substack…) (Figure 24).  
 
Figure 24. Creating substacks from larger stacks in order to get desired frames for 
another stack using the Make Substack setting. 
 
The desired slices, corresponding with either DIC or fluorescent channel, were 
entered into the Substack Maker dialogue box either in a range or list format 
(Figure 25). A new substack of either DIC or fluorescent images was then created 
and further processing continued. 
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Figure 25. Substack Maker dialogue box used to designate desired slices. 
 
Next, the scale for the images was set in order to convert measurements 
from pixels to micrometers. Values, taken from the computer program associated 
with the confocal microscope, were inputted into the set scale dialogue box 
(Figure 26). The program provided the conversion rate of 1.242 µm/pixel that was 
then inserted into the corresponding places with the pixel aspect ratio of 1.0 
stating that the 1.242 µm corresponded to 1 pixel. The global box was then 
selected so all images would have the same scale used during analysis. The Set 
Scale dialogue box then calculated the pixel to micron ratio to be 0.805 pixels/µm. 
Once all the appropriate options were selected, the box was closed with OK and 
image processing continued.  
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Figure 26. Setting the global scale of pixel to micron length to be applied to all 
images. 
Next, a montage was created to show how the microspheres moved down 
the channel in a series of images. In ImageJ, a series, such as the substack formed 
in the prior section, can be created into a single image file or montage (Image 
èStacks èMake Montage…) (Figure 27).   
 
Figure 27. Creating a montage from a stack of images using the Make Montage 
setting. 
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Once the Make Montage dialogue window opened, the desired information was 
filled in for each series of images (Figure 28). Since the background of all the 
images was black, the slices were labeled with the slice number by toggling on 
the Label Slices box. The Use Foreground Color box was not selected as the 
foreground color was black and black would not show up in the image. The 
column, row, first slice, last slice, and scale factor, or magnification level, 
numbers specified the layout of the resulting montage image. The Increment value 
denoted the slices or time between images displayed in the final image. The 
Border Width value was denoted to draw contrasting colored lines between 
images to easily discern the single images when combined in a single image.  
 
Figure 28. Settings used to create montage of images from stack. 
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The montage was then created as seen below (Figure 29). This image 
demonstrates how the microspheres moved along the channel due to pressure 
applied by a hand syringe. The image shows multiple microspheres entering the 
field from the right side and exiting the field of view on the left side of each 
image. The spheres flowing in and out of the field of view demonstrates 
uninhibited flow through the channel after the pressure on the syringe was 
released.  
 
	   	  	   	  63 
  
Figure 29.	  Montage of microspheres moving down channel of microfluidic chip due to pressure applied by 
a hand syringe. 
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From this montage, spheres can be seen flowing into the field of view 
from the right and out to the left in the channel of each frame. It can be 
determined that the channels were clear and allowed for fluid to flow since the 
spheres can be seen entering and exiting the field of view.  
The next step in the process was to try to determine the velocity of the 
spheres in the channel. In order to find the velocity of the spheres, the stack was 
separated into substacks if needed by following the steps previously described. 
The stacks or substacks were then separated into separate images in order to 
measure the distance traveled by the individual spheres. The individual images 
were then overlaid with one image over another and a line was drawn between the 
spheres in two locations (Figure 30). The distance was then measured by the 
program and recorded to use for further analysis.   
 
Figure 30. Measuring the distance spheres traveled between frames using ImageJ. 
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A total of 70 distance values were taken from the overlaid images and then 
entered into Microsoft Excel to calculate the average and standard deviation of the 
data. The time between frames was then calculated by multiplying the scan rate of 
the image by the size of the image. Next, the distance traveled per frame was 
divided by the time between frames in order to calculate the velocity at which the 
spheres traveled. Finally, the average and standard deviation of the data was taken 
and recorded.  
𝐼𝑚𝑎𝑔𝑒  𝑠𝑖𝑧𝑒   𝑝𝑖𝑥𝑒𝑙𝑓𝑟𝑎𝑚𝑒 ×  𝑆𝑐𝑎𝑛  𝑅𝑎𝑡𝑒   𝜇𝑠𝑒𝑐𝑝𝑖𝑥𝑒𝑙= 𝑇𝑖𝑚𝑒  𝐵𝑒𝑡𝑤𝑒𝑒𝑛  𝐹𝑟𝑎𝑚𝑒𝑠( 𝜇𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒) 
512×216 𝑝𝑖𝑥𝑒𝑙𝑓𝑟𝑎𝑚𝑒 × 2𝜇𝑠𝑒𝑐𝑝𝑖𝑥𝑒𝑙 = 221184   𝜇𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒   = 0.221184 𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒 
Table 5. Table of experimental values for pressure-driven flow of 10 um 
microspheres. 
 Average Standard Deviation 
Distance (µm) 87.86 68.62 
Velocity (µm/sec)  397.22 310.22 
 
Calculating the velocity of the spheres traveling down the channel 
provided experience with ImageJ to develop a method to determine the velocity at 
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which particles travel through channels in a microchip. With this knowledge, 
further progress was possible as the microchip was validated.   
 
MDA 
 The next test was to perform the pressure-driven microsphere test again, 
but replaced the microspheres with a solution of MDA and TBA in deionized 
water used to verify that the MDA solution would flow through the channels and 
pressure driven flow could be used if voltage driven flow failed. Malondialdehyde 
tetrabutylammonium salt and 2-Thiobarbituric acid (Sigma-Aldrich, St. Louis, 
MO) were handled inside the fume hood using appropriate protective precautions 
including gloves, long sleeved shirts, long pants, closed toe shoes, and goggles. 
Three concentrations of MDA solutions were created, 10mM, 20µM, and 
0.02µM, following the Fluorometric TBARS Miccroplate Assay Kit protocol 
(Oxford Biomedical Research Inc., 2012). The solutions were used to run through 
the system in order to determine if any concentration would block the flow 
through the channel and that different concentrations could be detected. The 
solutions were also used in later experiments involving MDA solutions. A 10mM 
MDA solution was first made by taring the scale with a 10 mL conical tube then 
weighing out approximately 0.0313 grams of the MDA salt into the conical tube. 
Next, 10 mL of deionized water was added to the conical tube and vortexed for 
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approximately 30 seconds. Then, the 10mM solution was diluted 1:500 in 
deionized water by adding 20 µL of 10 mM MDA to 9.98 mL of deionized water 
to make a 20µM MDA solution. The solution was further diluted 1:1,000 in 
deionized water by adding 10 µL of 20µM MDA solution to 9.99 mL of 
deionized water to make a 0.02µM MDA solution.  
 The TBA assay was then prepared by tarring the scale with a 10 mL 
conical tube then weighing out approximately 1.0 gram of the TBA powder into 
the conical tube. Next, 10 mL of deionized water was added to the conical tube 
and shaken by hand until the powder had dissolved. Both the MDA and TBA 
solutions were made directly prior to use.  
 The microfluidic chip was again set up on the confocal microscope using 
the fabricated holder and taped together (Figure 31). Male luer connectors were 
attached to the microchip at the buffer and buffer waste reservoirs. A male to 
female luer connector was then attached to the chip and a female to female elbow 
connector for both ends of the chip. Next, a male to barbed luer connector was 
attached to a short piece of 1/8 inch tubing. The waste end then had a paper towel 
under the tube to collect the waste fluid. The buffer input end had had another 
male barbed luer connector to a female to female connection for the syringe 
attachment. The sample and sample waste reservoirs had caps to prevent fluid 
from flowing into the channels.  
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Figure 31. Set up of pressure-driven MDA test without chip holder and not on 
confocal microscope. 
 
 The tests followed the Fluorometric TBARS Miccroplate Assay Kit 
protocol (Oxford Biomedical Research Inc., 2012) to test different concentrations 
of MDA in solution. The first test was composed of 1 mL of 10 mM MDA 
solution with 0.5 mL of TBA assay in a 50 mL conical tube which was then 
vortexed (~30 seconds). Once vortexed, the solution turned from clear to fuchsia. 
First, the channels of the microchip were primed with deionized water from a 
syringe. Next, the syringe was filled with the TBA/MDA solution and slowly 
injected into the system while on the confocal microscope stage. Minor pressure 
by handheld injection was used to inject the sample into the microchip. Desired 
images were taken at 20x with a scan rate of 2 µsec/frame and saved as .oib files 
and exported as .tif files. The files must be saved as .oib as it is the standard 
Olympus format required to save the settings for the microscope. The channels 
were then cleared with deionized water.  
The chip was then tested with a lower concentration of MDA solution in 
order to determine if the chip could be used to detect lower MDA concentrations 
	   	  	   	  69 
in a sample. Another MDA/TBA solution was made with the 1.0 mL of the 0.02 
µM MDA solution and 0.5 mL of the TBA assay in a 50 mL conical tube which 
was then vortexed (~30 seconds) following the protocol. Once vortexed and 
approximately 3 minutes, the solution turned from clear to fuchsia. The syringe 
was then filled with the TBA/MDA solution and connected to the microchip. 
Again, the solution was injected into the microchip using handheld pressure and 
desired images were taken at 20x. The channels were again cleaned with 
deionized water from a syringe connected to the system. 
 Finally, the chip was again tested with the lowest concentration of MDA 
solution in order to determine if the chip could be used to detect a significantly 
lower MDA concentration in a sample. A solution of 2.0 mL 10 mM MDA 
solution and 0.5 mL of TBA assay were combined in a 50 mL conical tube which 
was then vortexed (~30 seconds). Once vortexed, the solution turned from clear to 
fuchsia after approximately 2 minutes. Again, a syringe was filled with the 
TBA/MDA solution and connected to the microchip. The solution was then 
injected into the microchip using handheld pressure and desired images were 
taken at 20x. The channels were again cleaned with deionized water from a 
syringe connected to the system. 
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ImageJ Results & Analysis 
ImageJ was used again to analyze the images taken of the pressure-driven 
MDA flow in order to verify the presence of MDA flowing through the channel. 
With the existence of MDA in the channel, the chip can continue to be tested with 
electrophoresis and if voltage-driven flow fails, pressure-driven flow can be used. 
Before any MDA was injected into the channel, an image of the channel was 
taken (Figure 32). The sides of the channel were defined by the thicker, more 
intense green light and the light inside the channel may be caused by 
autofluorescence of the fused silica chip. 
 
Figure 32. Image of empty channel after washing with deionized water. 
 
Next, the scale for the images was set in order to convert measurements 
from pixels to micrometers. Values, taken from the computer program associated 
with the confocal microscope, were inputted into the set scale dialogue box 
(Figure 33). The program provided the conversion rate of 1.242 µm/pixel that was 
then inserted into the corresponding places with the pixel aspect ratio of 1.0 
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stating that the 1.242 µm corresponded to 1 pixel. The global box was then 
selected so all images would have the same scale used during analysis. The Set 
Scale dialogue box then calculated the pixel to micron ratio to be 0.805 pixels/µm. 
Once all the appropriate options were selected, the box was closed with OK and 
image processing continued.  
 
Figure 33. Setting the global scale of pixel to micron length to be applied to all 
images. 
The channels were then separated in the stack in order to analyze the two 
channels independently as the MDA may look differently in the channels. To 
separate the channels and frames, substacks were created (Image èStacks èTools 
èMake Substack…) (Figure 34).  
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Figure 34. Creating substacks from larger stacks in order to get desired frames for 
another stack using the Make Substack setting. 
The desired slices, corresponding with either DIC or fluorescent channel, were 
entered into the Substack Maker dialogue box either in a range or list format 
(Figure 35). A new substack of either DIC or fluorescent images was then created 
and further processing continued in order to observe the MDA flow down the 
channel. 
 
Figure 35. Substack Maker dialogue box used to designate desired slices. 
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Next, a montage was created to show how the MDA/TBA solution moved 
down the channel in a series of images. In ImageJ, a series, such as the substack 
formed in the prior section, can be created into a single image file or montage 
(Image èStacks èMake Montage…) (Figure 36).   
 
Figure 36. Creating a montage from a stack of images using the Make Montage 
setting. 
 
Once the Make Montage dialogue window opened, the desired information was 
filled in for each series of images (Figure 37). Since the background of all the 
images was black, the slices were labeled with the slice number by toggling on 
the Label Slices box. The Use Foreground Color box was not selected as the 
foreground color was black and black would not show up in the image. The 
column, row, first slice, last slice, and scale factor, or magnification level, 
numbers specified the layout of the resulting montage image. The Increment value 
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denoted the slices or time between images displayed in the final image. The 
Border Width value was denoted to draw contrasting colored lines between 
images to easily discern the single images when combined in a single image.  
 
Figure 37. Settings used to create montage of images from stack. 
 
The montage was then created in order to see when the MDA entered and 
exited the field of view (Figure 38). This image demonstrates how the MDA, 
appears green in the images, moved along the channel due to pressure applied by 
a hand syringe. The image shows the MDA entering the field from the right side, 
in images 120 and 132, and exiting the field of view on the left side, in image 121, 
and continuously flowing, images 132 through 140. The MDA flowing in and out 
of the field of view, as seen by the green areas appearing and disappearing, 
demonstrates uninhibited flow through the channel after the pressure on the 
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syringe was released. The next step in the process was to try to determine the 
velocity of the MDA in the channel.  
 
 
Figure 38. Montage of slices 120-140 of 200 image stack, showing MDA fluid in 
the channel, leaving the channel, and re-entering the channel. 
In order to find the velocity of the MDA, the stack was separated into 
substacks if needed by following the steps previously described. The stacks or 
substacks were then separated into separate images in order to measure the 
distance traveled by the MDA. The individual images were then overlaid with one 
image over another and a line was attempted to be drawn between the areas of 
MDA in two locations. Unfortunately, in all the images, it was impossible to 
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distinguish any locations on the images in which to measure the distance the 
MDA traveled between frames (Figure 39). Without knowing the distance 
traveled between frames, velocity could not be accurately calculated. The MDA 
may have been moving at a faster velocity than that of the 2 µs/pixel scan rate, 
therefore it was unable to pick a point in two images that could be used to 
measure the distance traveled. 
 
Figure 39. Attempting to measure the distance spheres traveled between frames 
using ImageJ. 
 
Although the exact velocity could not be calculated, the time between 
frames was calculated by multiplying the scan rate of the image by the size of the 
image. Next, the distance traveled per frame was assumed to be greater than or 
equal to the width of the field of view. This distance was then divided by the time 
between frames in order to calculate the approximate velocity at which the 
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spheres traveled (Table 6). This value was not accurate but was calculated as 
practice for later measurements.  
𝐼𝑚𝑎𝑔𝑒  𝑠𝑖𝑧𝑒   𝑝𝑖𝑥𝑒𝑙𝑓𝑟𝑎𝑚𝑒 ×  𝑆𝑐𝑎𝑛  𝑅𝑎𝑡𝑒   𝜇𝑠𝑒𝑐𝑝𝑖𝑥𝑒𝑙= 𝑇𝑖𝑚𝑒  𝐵𝑒𝑡𝑤𝑒𝑒𝑛  𝐹𝑟𝑎𝑚𝑒𝑠( 𝜇𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒) 
512×228 𝑝𝑖𝑥𝑒𝑙𝑓𝑟𝑎𝑚𝑒 × 2𝜇𝑠𝑒𝑐𝑝𝑖𝑥𝑒𝑙 = 233472   𝜇𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒   = 0.233472 𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒 
Table 6. Table of approximated values for pressure-driven flow of MDA solution. 
Distance (µμm) Velocity (µμm/sec  ) 
512 2192.98 
 
Although calculating the velocity of the MDA traveling down the channel 
was not possible, the test did demonstrate the ability to view MDA in the channel. 
It also provided experience with ImageJ to develop a method to determine the 
velocity at which MDA travel through channels in a microchip. Furthermore, the 
images demonstrate the ability to detect MDA using a confocal microscope. With 
this knowledge, further progress was possible as the microchip was validated. It 
was also determined that pressure-driven flow of MDA could be used for 
detection in the future if voltage-driven flow failed. 
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Model of Microchip Capillary Electrophoresis System  
The microchip was then set up for capillary electrophoresis as described in 
the Final Design Proof of Concept (Figure 21 and 40). Electrodes were created by 
stripping wires to expose the metal from a pre-made kit for gel electrophoresis 
(Bio-Rad, Hercules, CA). The stripped wires were then threaded through the 
barbed end of male luer connectors and attached via heat shrink wrap. Alligator 
clips at the other end were able to connect to banana plugs leading to the voltage 
source. A female to male connector attached to the chip and a female to female 
connector. Next, an all female t-connector was attached with the electrode male 
luer connector and syringe were attached to the top ports for the buffer input well 
and just an electrode connector at the waste end. The cathode electrode was 
placed at the waste well and the anode was placed at the buffer/sample input well.  
 
Figure 40. Labeled image of the CE system setup with the microchip that was 
used in the previous experiments.  
Alligator	  Clips 
Banana	  Plugs 
Electrodes 
Microchip 
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Confocal Microscope Imaging 
 After the CE system was set up with the microchip, the system was placed 
on the microscope in order to view the microspheres or MDA solution flow 
through the channel.  
Microspheres 
 The purpose of this experiment was to learn if the CE system was set up 
correctly and to learn techniques to make the process smoother. The microchip 
was placed onto the confocal microscope with the syringe containing 600 µL 
microspheres/5 mL deionized water prepared with the same preparation as 
previously described. An arbitrary location along the channel was again found 
using the same process as previously described. An image was then taken as a 
control for the channel. Pressure was slowly applied to the syringe by hand to 
inject the channel with the microspheres. The voltage source was then turned on 
and voltage was applied starting with 20V, then 40V, and finally 48.8V. The first 
two voltages, 20V and 40V, were arbitrarily selected and the 48.8V was selected 
as it was the highest voltage possible with the voltage source provided.  
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Figure 41. Bench model of CE system setup on the confocal microscope with the 
voltage source. 
Images were taken using the FluoView software on the corresponding 
computer to view the microspheres moving along the channel a single-plane at a 
time. The images were taken by scanning a laser across the sample on a single 
plane over time with a scan rate of 2 µs/pixel. After the desired time, scanning 
ended and the image files were defaultly saved as .oib file types and then exported 
as .tif files to process later. The .oib file type is the standard Olympus format 
necessary to save all information related to the microscope settings. The files need 
to be in .tif format for processing in the desired program, ImageJ. 
Voltage	  Source 
Alligator	  Clips 
Banana	  Plugs 
Confocal	  
Microscope 
Electrodes 
Microchip 
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When the syringe remained in the system, the microspheres appeared to 
flow in the direction reverse to the polarity of the charge. The syringe was then 
removed and the spheres then flowed in the direction of the polarity of the charge 
and some even stopped. When the syringe was removed, the residual pressure 
from the pressure was able to quickly dissipate causing the spheres to flow in the 
direction of the applied voltage. With the syringe removed from the system, a test 
was performed to see if the charge was directing the flow of the microspheres.  
The purpose of the secondary test was to determine if the directionality of 
the microspheres was based on the charge applied to the system. In order to 
decide if the spheres flow was based on the applied charge, the directionality of 
the charge was reversed to verify that the spheres would reverse flow. The system 
was turned on with the original charge directionality of cathode, positive charge, 
in the waste well and anode, negative charge, in the sample well of the chip. After 
a few minutes, the voltage source was then turned off and the electrodes were 
switched at the alligator-banana clip end and the voltage turned back on with the 
charge in the reverse directions. The microspheres changed direction to flow 
toward the cathode which was located in the sample well. This voltage shift was 
attempted multiple times with at various times between shifting voltages, with the 
same result. Voltage was then turned off and the microspheres continued to flow 
down the channel. The channel was then cleaned with deionized water via a 
syringe injected with hand pressure.  
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ImageJ Results & Analysis 
ImageJ was used again to analyze the images taken of the voltage-driven 
microspheres in order to determine if the CE system was properly set up to drive 
the microspheres through the channel.  
First, the image files were opened in ImageJ the scale for the images was 
set in order to convert measurements from pixels to micrometers. Values, taken 
from the computer program associated with the confocal microscope, were 
inputted into the set scale dialogue box (Figure 42). The program provided the 
conversion rate of 1.242 µm/pixel that was then inserted into the corresponding 
places with the pixel aspect ratio of 1.0 stating that the 1.242 µm corresponded to 
1 pixel. The global box was then selected so all images would have the same scale 
used during analysis. The Set Scale dialogue box then calculated the pixel to 
micron ratio to be 0.805 pixels/µm. Once all the appropriate options were 
selected, the box was closed with OK and image processing continued.  
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Figure 42. Setting the global scale of pixel to micron length to be applied to all 
images. 
The channels were then separated in the stack in order to analyze the two 
channels independently as the microspheres may look differently in the channels. 
To separate the channels and frames, substacks were created (Image èStacks 
èTools èMake Substack…) (Figure 43).  
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Figure 43. Creating substacks from larger stacks in order to get desired frames for 
another stack using the Make Substack setting. 
The desired slices, corresponding with either DIC or fluorescent channel, were 
entered into the Substack Maker dialogue box either in a range or list format 
(Figure 44). A new substack of either DIC or fluorescent images was then created 
and further processing continued in order to observe the microspheres flow down 
the channel. 
 
Figure 44. Substack Maker dialogue box used to designate desired slices. 
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Next, a montage was created to show how the microspheres moved down 
the channel in a series of images. In ImageJ, a series, such as the substack formed 
in the prior section, can be created into a single image file or montage (Image 
èStacks èMake Montage…) (Figure 45).   
 
Figure 45. Creating a montage from a stack of images using the Make Montage 
setting. 
 
Once the Make Montage dialogue window opened, the desired information was 
filled in for each series of images (Figure 46). Since the background of all the 
images was black, the slices were labeled with the slice number by toggling on 
the Label Slices box. The Use Foreground Color box was not selected as the 
foreground color was black and black would not show up in the image. The 
column, row, first slice, last slice, and scale factor, or magnification level, 
numbers specified the layout of the resulting montage image. The Increment value 
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denoted the slices or time between images displayed in the final image. The 
Border Width value was denoted to draw contrasting colored lines between 
images to easily discern the single images when combined in a single image.  
 
Figure 46. Settings used to create montage of images from stack. 
The montage was then created in order to see when the microspheres 
entered and exited the field of view and the directionality of the microspheres 
(Figure 47).  
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Figure 47. Montage of images, in numerical order, demonstrating the flow of a 
single microsphere, circled in red, flowing down the channel, from right to left of 
the channel, in the same direction as the electric field. 
This image demonstrates how the microspheres moved along the channel 
in the same direction as the electric field, due either to pressure applied by the 
hand syringe or by the applied electric field. The sequence of images follows in 
numerical order starting in the first image in the top left corner and ending in the 
bottom right corner. Each image shows the microspheres entering the field from 
the right side of the channel in each image, and exiting the field of view on the 
left side of each image, (Figure 47). The next step in the process was to try to 
determine the velocity of the spheres in the channel.  
In order to find the velocity of the microspheres, the stack was separated 
into substacks if needed by following the steps previously described. The stacks 
or substacks were then separated into separate images in order to measure the 
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distance traveled by the individual spheres. The individual images were then 
overlaid with one image over another and a line was attempted to be drawn 
between the areas of microspheres in two locations (Figure 48). The distance was 
then measured by the program and recorded to use for further analysis. 
 
Figure 48. Measuring the distance between microspheres flowing down the 
channel due to voltage-flow. 
 
A total of 120 values were taken from the overlaid images and then 
entered into Microsoft Excel to calculate the average and standard deviation of the 
data. The time between frames was then calculated by multiplying the scan rate of 
the image by the size of the image. Next, the distance traveled per frame was 
divided by the time between frames in order to calculate the velocity at which the 
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spheres traveled. Finally, the average and standard deviation of the data was taken 
and recorded and compared with the calculated values (Table 7).  
𝐼𝑚𝑎𝑔𝑒  𝑠𝑖𝑧𝑒   𝑝𝑖𝑥𝑒𝑙𝑓𝑟𝑎𝑚𝑒 ×  𝑆𝑐𝑎𝑛  𝑅𝑎𝑡𝑒   𝜇𝑠𝑒𝑐𝑝𝑖𝑥𝑒𝑙= 𝑇𝑖𝑚𝑒  𝐵𝑒𝑡𝑤𝑒𝑒𝑛  𝐹𝑟𝑎𝑚𝑒𝑠( 𝜇𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒) 
512×216 𝑝𝑖𝑥𝑒𝑙𝑓𝑟𝑎𝑚𝑒 × 2𝜇𝑠𝑒𝑐𝑝𝑖𝑥𝑒𝑙 = 221184   𝜇𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒   = 0.221184 𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒 
Table 7. Table of values for voltage-driven flow of 10 um microspheres. 
 Average Standard Deviation 
Distance (µμm) 72.12 11.88 
Velocity (µμm/sec) 326.05 53.70 
Theoretical 
Velocity 
(µμm/sec) 8.159 x 10-3  
Percent Error 39961%  
 
Calculating the velocity of the spheres traveling down the channel allowed 
for a comparison between the calculated velocity versus the experimental values 
in order to better understand the experimental CE system. The calculated velocity 
was calculated using the Debye-Huckel-Henry theory to calculate the 
electrophoretic mobility, µep, which was used to calculate the electrophoretic 
velocity, vep [36] (Table 8). 
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Table 8. Variables used to calculate velocity of voltage-driven microspheres. 
Variable Definition Assumed Value 
q Net charge of particle 6 x 10-19 C 
R Stokes radius of particle 5 µm 
η Viscosity of solution 1.002 mPa-s 
E Electric Field Strength 1284.21 V/m 
 𝜇!" = 𝑞6𝜋𝜂𝑅 = 6.35  ×  10!!"   𝑚! 𝑉 ∙ 𝑠 𝑉!" =   𝜇!"𝐸 =   8.159  ×  10!!𝑚 𝑠 =   8.159  ×10!! 𝜇𝑚 𝑠   
After calculating the two velocities, it was clear that there is was a large 
difference between the experimental and calculated values. With this knowledge, 
it is very difficult to determine if the CE system was effective in transporting the 
spheres down the channel. The images of the spheres with the shifting voltages 
were then analyzed to determine if the spheres were driven by voltage.  
The second test allowed the spheres to settle more and allow the residual 
effects of the pressure of injection to diminish. The voltage was reversed two 
times, causing the spheres to reverse directionality each time the voltage changed. 
Figure 49 shows the spheres flowing from left to right in the channel in row A, 
then reversing the polarity so the spheres flowed from right to left in row B, and 
finally reversing to the original polarity of left to right in row C.  
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Figure 49. Voltage-driven flow of 10 um spheres shifted by reversing the polarity 
of the electrodes with A) spheres flowing from left to right in the channel, B) 
reversing polarity so spheres flowed from right to left, and C) final polarity shift 
with spheres traveling from left to right.  
 The absolute value of 200 distances values were recorded and the average 
velocity was calculated in the same way as previously described (Table 9). The 
velocity of the spheres due to the voltage was closer to the theoretical value than 
the first experiment with the syringe in place and immediately after the pressure 
was applied.  
Table 9. Table of values for voltage-driven flow of 10 um microspheres. 
 Average Standard Deviation 
Distance (µμm) 2.438 1.151 
Velocity (µμm/sec) 11.025 5.203 
Theoretical 
Velocity 
(µμm/sec) 8.159 x 10-3  
Percent Error 1350.27%  
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Potential differences in velocity between theoretical and calculated values could 
be due to a variety of reasons. One main reason for the difference could be that 
the residual pressure from the injection of the spheres continued to move the 
spheres and overcame the velocity created by the voltage. Another potential 
reason could be a form of vacuum is created on the input end when the spheres 
are injected leading to the spheres being moved due to a difference in pressure on 
either end even after the pressure is released. If the syringe is removed, the 
pressure can equalize over time and the resulting movement would be due to the 
applied voltage.  
The next experiment replaced the microspheres with an MDA solution and 
the experiment was performed again in order to see if the CE system would be 
successful in driving the MDA particles down the channel.  
  
 
MDA 
The next experiment was designed to validate the proof-of-concept CE 
system to detect MDA in order to determine if it was feasible to proceed with the 
design. 
A new syringe was filled with the solution of MDA prepared in the 
method previously discussed. An arbitrary location of the channel was selected 
and imaged prior to injection as a control. The syringe was then inserted into the 
	   	  	   	  93 
port and slight pressure was applied by hand to inject the MDA into the channel. 
Images were taken without voltage. The voltage supply was then turned on to 40V 
with the cathode in the waste well and the anode in the buffer well. The voltage 
was then turned up to 48.8V, the maximum voltage possible on the given voltage 
source, to increase the speed at which the MDA would reach the field of view. 
The sample then flowed past the point of interest with a parabolic shape. The 
parabolic shape was unusual as capillary electrophoresis is supposed to flow as a 
flat shape and parabolic plug are produced by pressure driven flow. The voltage 
was then turned off and some flow was still seen. This flow could be due to 
residual effects of the electrical signal or differences in pressure along the 
channel. The channel was then cleaned with deionized water injected by a 
syringe.  
ImageJ Results & Analysis 
The following (Figure 50 through Figure 55) are selected images from the 
sequence where the voltage was applied and flow was seen with a parabolic 
shape. The first image shows the channel after being washed with deionized 
water, before the MDA enters the channel (Figure 50). 
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Figure 50. Slice 1 of 200 showing the microchannel with no MDA present. 
 
The next image shows the MDA solution filling the entire channel in the field of 
view as seen by the vibrant green color (Figure 51). The leading and trailing end 
of the plug is not visible therefore it cannot be determined if the plug is driven by 
pressure or voltage. The velocity of the MDA solution was greater than the scan 
rate of the frame thus the leading portion of the MDA was not imaged.  
 
Figure 51. Slice 20 of 200 showing the presence of MDA known by the increased 
intensity of the fluorescence in the channel. 
Next, the MDA can be seen in the field of view of the channel with parabolic flow 
seen in the front and back of the MDA plug (Figure 52). The parabolic shape 
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could due to an air bubble in the channel resulting from the pressure from the 
syringe injection. The parabolic shape of the MDA in the channel could also be 
due to pressure-driven flow. However the most likely scenario is that there were 
air bubbles in the channel because the parabola at the leading end of the plug is 
facing the wrong direction if it was driven by pressure. 
 
 
Figure 52. Slice 23 of 200 with MDA present with parabolic flow leading and 
following the fluid. 
 
In the next image, the MDA can again be seen in the field of view of the channel 
with parabolic flow seen in the front of the MDA plug showing that the MDA 
continued down the channel with an air bubble on either side of the MDA plug 
(Figure 53). 
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Figure 53. Slice 24 of 200 with MDA present with parabolic flow following the 
fluid. 
Following plug, the MDA can again be seen in the field of view of the channel 
with a sharp half-parabolic flow seen in the front of the MDA plug showing that 
the MDA continued down the channel with an air bubble present in the channel 
(Figure 54).  
 
Figure 54. Slice 25 of 200 with MDA present in the top left corner of the channel 
in the region of interest, with a parabolic shape following the fluid. 
 
Finally, the last image has the MDA solution filling the entire channel in the field 
of view as seen by the vibrant green color (Figure 55). The leading and trailing 
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end of the plug is not visible therefore it cannot be determined if the plug is driven 
by pressure or voltage. 
 
Figure 55. Slice 28 of 200 with MDA present in the microchannel as seen by the 
increased intensity of fluorescence. 
After viewing the flow of MDA in the channel, the velocity of the MDA 
was determined using ImageJ. The stack was separated into substacks if needed 
by following the steps previously described. The stacks or substacks were then 
separated into separate images in order to measure the distance traveled by the 
individual spheres. The individual images were then overlaid with one image over 
another and a line was drawn between the areas of MDA in two locations (Figure 
56). 
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Figure 56. Measuring the distance traveled by the MDA solution in the channel. 
 
A total of 5 distance values were determined from the overlaid images and 
were then entered into Microsoft Excel to calculate the average and standard 
deviation of the data. The time between frames was then calculated by 
multiplying the scan rate of the image by the size of the image. Next, the distance 
traveled per frame was divided by the time between frames in order to calculate 
the velocity at which the spheres traveled. Finally, the average and standard 
deviation of the data was taken and recorded (Table 10).  
𝐼𝑚𝑎𝑔𝑒  𝑠𝑖𝑧𝑒   𝑝𝑖𝑥𝑒𝑙𝑓𝑟𝑎𝑚𝑒 ×  𝑆𝑐𝑎𝑛  𝑅𝑎𝑡𝑒   𝜇𝑠𝑒𝑐𝑝𝑖𝑥𝑒𝑙= 𝑇𝑖𝑚𝑒  𝐵𝑒𝑡𝑤𝑒𝑒𝑛  𝐹𝑟𝑎𝑚𝑒𝑠( 𝜇𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒) 
512×228 𝑝𝑖𝑥𝑒𝑙𝑓𝑟𝑎𝑚𝑒 × 2𝜇𝑠𝑒𝑐𝑝𝑖𝑥𝑒𝑙 = 233472   𝜇𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒   = 0.233472 𝑠𝑒𝑐𝑓𝑟𝑎𝑚𝑒 
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Table 10. Table of values for voltage-driven flow of MDA solution. 
 Average Standard Deviation 
Distance (µμm) 38.67 3.99 
Velocity (µμm/sec) 165.62 17.08 
Theoretical 
Velocity 
(µμm/sec) 141.9  
Percent Error 16.72%  
 
Calculating the velocity of the MDA traveling down the channel allowed 
for a comparison between the calculated velocity versus the experimental values 
in order to better understand the experimental CE system. The calculated velocity 
was calculated using the Debye-Huckel-Henry theory to calculate the 
electrophoretic mobility, µep, which was used to calculate the electrophoretic 
velocity, vep [36] (Table 11). 
Table 11. Variables used to calculate velocity of voltage-driven MDA. 
Variable Definition Assumed Value 
q Net charge of particle 2.4 x 10-18 C 
R Stokes radius of particle 1.15 x 10-9 m 
η Viscosity of solution 1.002 mPa-s 
E Electric Field Strength 1284.21 V/m 𝜇!" = 𝑞6𝜋𝜂𝑅 = 1.105  x  10!!𝑚! 𝑉𝑠 
𝑉!" =   𝜇!"𝐸 = 1.482  × 10!!𝑚𝑠 = 141.899𝜇𝑚/𝑠 
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There was some variation between experimental and calculated velocities 
for the MDA solution. The CE system needs to be further analyzed in order to 
explore the areas of variability that may have caused the discrepancy in velocity 
of the MDA fluid prior to next generation development. 
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Discussion and Conclusion 
Traumatic brain injuries are a large problem especially for military 
personnel. Currently there is a need for field detection of TBIs in order to 
diagnose patients earlier to increase their care and ultimately quality of life. TBIs 
produce a cascade that includes an increase in production of reactive oxygen 
species leading to an oxidative state in the body. This oxidative state can cause 
further injuries especially to the brain, such as neuronal degeneration. There are 
many types of ROS found when the body is in an oxidative state including 
malondialdehyde. MDA can be found in many bodily specimens including plasma 
in blood, and it can be detected in a variety of methods including capillary 
electrophoresis. Current technologies for CE include lab-on-a-chip or a 
microfluidic chip.  
Pressure-Driven Flow on Confocal Microscope 
 The test for pressure-driven flow of microspheres was designed to confirm 
an accurate fluid flow from the sample well to the sample waste well through the 
sample and separation channels. Viewing the microspheres flow in and out of the 
field of view demonstrated that the fluid could flow uninhibitly through the 
sample and separation channels. ImageJ was then used to calculate the velocities 
at which the spheres traveled through the field of view from pressure-driven flow. 
The average velocity of spheres traveling down the channel was 397.22 µm/sec 
however the standard deviation was 310.22 µm/sec. The large standard deviation 
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could be due to the different paths the spheres traveled. Some of the spheres 
traveled faster than the scanning speed therefore their distance could not be 
calculated, while others may have bounced off the sides of the channel causing 
variations in velocities. Once it was determined that fluid could flow through the 
channels and the confocal microscope could view the channel, MDA was then 
exchanged for the microspheres. 
 The MDA solution was then used for pressure-driven flow through the 
chip in order to verify that the fluid could flow through the sample and separation 
channels between the sample well and sample waste well. In addition, the 
experiment demonstrated that the MDA solution could be detected using a 
confocal microscope and that pressure could be used to drive the fluid through the 
channels if the voltage failed during CE. The average velocity of MDA with 
pressure-driven flow was estimated to be 2192.98 µm/sec. This is an inaccurate 
estimate due to the inability to detect a specific location to track over time within 
the fluid flow. The failure to detect a specific location could be due to the fluid 
flowing at a greater velocity than that of the scan speed of the confocal 
microscope or due to the plug flowing longer than the field of view. Without two 
specific points over time, it was impossible to calculate the experimental velocity 
of the MDA solution due to pressure-driven flow. Although the exact velocity 
could not be determined, the fluid was seen flowing through the field of view, 
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which verified that the MDA flowed through the sample and separation channels 
between the sample and sample waste wells.  
It should be noted that one source of error, for all of the experiments in 
this study, is human error. The locations selected in ImageJ, used to calculate the 
distance traveled by the spheres or MDA solution, were locations determined by a 
person and therefore not precise. From the results from the pressure-driven flow 
experiments, it can be concluded that pressure could be used to drive the system if 
the CE system fails.  
Voltage-Driven Flow on Confocal Microscope 
The test for voltage-driven flow of microspheres on the confocal 
microscope was to learn if the CE setup was suitable and determine a procedure 
for the experimental CE system. The microsphere sample was injected into the 
sample channel from the sample well and the electric field was induced between 
the sample and sample waste wells. The spheres were observed entering and 
exiting the field of view on the confocal microscope demonstrating that the 
spheres flowed down the channel. From this observation, it was assumed that the 
CE system successfully created an electric field which drove the spheres down the 
channel. The average velocity of the spheres during this experiment was 326.05 
µm/sec which was significantly greater than the theoretical velocity of 0.0082 
µm/sec. The disparity between the theoretical and experimental velocities could 
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be a result of the spheres continuously being driven by pressure even though the 
pressure source had been removed for an extended period of time. After 
comparing the average velocities from experimental data between pressure-driven 
and voltage-driven flow, 397.22 µm/sec as compared to 326.05 µm/sec 
respectively, the conclusion could be drawn that the spheres flowed down the 
channel due to the applied pressure from the syringe. 
Conversely, the second experiment for the voltage-driven flow of 
microspheres, demonstrated that voltage played a large role in the movement of 
the particles. The average velocity of the spheres during the voltage shifting 
experiment was 11.025 µm/sec which is closer to the theoretical value of 0.0082 
µm/sec. By removing the syringe and allowing more time to pass, the particles 
were able to settle in the channel and the effects of the residual pressure 
decreased. However, if the spheres wait too long, the spheres will settle on the 
bottom of the channel which can be difficult to move and may require the 
pressure to be applied again. After the second experiment, it could be concluded 
that the applied voltage played a large role in the movement of the spheres after 
allowing enough time for the residual pressure to dissipate.  
The purpose of the voltage-driven flow of MDA on the confocal 
microscope was to validate the proof-of-concept CE system to determine if the 
model was feasible to proceed. The MDA solution was injected into the sample 
channel from the sample well and the electric field was induced between the 
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sample and sample waste wells. The average velocity of the MDA during this 
experiment was 165.62 µm/sec which was greater than the theoretical velocity of 
141.9 µm/sec. The disparity between the theoretical and experimental velocities 
could be a result of the MDA continuing being driven by pressure even though the 
pressure source had been removed for an extended period of time. The 
significantly smaller size of the MDA particles when compared to the spheres, 
make it impossible to track any single MDA particle to determine a more precise 
velocity. The only way it was possible to calculate the velocity of the MDA 
solution was due to the parabolic shapes leading and following plugs created by 
air bubbles in the system. To reduce these air bubbles and allow for continuous 
flow, the syringe can be void of all air bubbles prior to attaching it to the system. 
In addition, the channel can be completely flushed with the MDA solution prior to 
removing the syringe to remove any air bubbles from the channel.  
The assumed conclusion from the project is that the proof-of-concept CE 
system was successful after the pressure from the injection subsided and allowed 
the spheres and MDA to flow down the channel during all tests. It should be noted 
that the theoretical velocity was calculated using assumed values. These values, 
such as viscosity of the buffer solution, vary depending on a variety of factors 
including temperature of the solution which is increased as the voltage is applied 
for extended periods of time. One problem with the current experiments was that 
enough time did not pass after the pressure was used to inject the fluid into the 
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channel. If the fluid had time to decrease velocity prior to the application of the 
electric field, the fluid would then be purely driven by voltage. On the other hand, 
an increased voltage would either accelerate the fluid to a velocity greater than 
that caused by pressure or maintain the velocity of the fluid that was created by 
pressure. There are many risks associated with an increased voltage, which can 
make the system dangerous for the user. From these conclusions, it can be 
discerned that further experimentation and development is necessary to determine 
the feasibility of a portable TBI detection device.
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Future Work and Recommendations 
 There are many areas for future improvement and development of the 
current work in order to create a portable TBI detection device. The following 
describes a few suggestions on improvements of the experiments performed in 
this study. 
Pressure-Driven Flow on Confocal Microscope 
 The pressure-driven flow of both the spheres and the MDA solution could 
have been explored more thoroughly in order to better understand the equipment 
prior to beginning experiments with voltage-driven flow. The pressure to the 
syringe, used to inject the solutions into the channel of the chip, can be applied 
using a syringe pump therefore knowing an exact pressure to calculate an 
approximate velocity of the fluids as they flow down the channel. With the 
syringe, removing all air bubbles from the syringe and the channel will help in the 
voltage-driven portion so the air bubbles do not disrupt the flow of fluids through 
the channel. Another area of improvement would be to use a different solution for 
the run buffer, as opposed to the deionized water. Observing the fluid flow of 
different buffer solutions, such as any from the articles found in Table 2, with a 
known applied pressure could be used as a form of control for the voltage 
experiments with the same buffer solutions. Finally, flowing fluid through the 
buffer and buffer waste wells with pressure-driven flow could help characterize 
the buffer sample channels to use with voltage-driven flow for later experiments. 
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Characterizing the microchip with pressure-driven flow provides an avenue that 
may be considered a better method of analysis of MDA detection in a sample than 
capillary electrophoresis.  
Voltage-Driven Flow on Confocal Microscope 
 From the data, it was cannot be concluded that the voltage-driven flow 
was successful or unsuccessful in this study therefore allowing for a multitude of 
improvements. First, duplicating one to two experiments from the studies found in 
Table 2 with the microchip, can aid in better understanding the process of 
capillary electrophoresis. In order to follow the protocols, the run buffer solution 
described in the experiment would be used in place of the deionized water as the 
buffer has proven success in prior experiments. In addition to the buffer, the high 
voltage would need to be applied to the system to induce the high electric field. 
The high voltage continues the movement of the solution down the channel after 
the pressure is removed from injecting the samples into the channel. Increasing 
the voltage to the kilovolt range, should mimic the experiments described in the 
papers, Table 2, which have been concluded to have successfully demonstrated 
CE. Furthermore, the conditions should be tested with a tabletop system prior to 
being injected into the microchip to verify that the buffer and voltages effectively 
transport the particles down the capillary. Finally, the injection method of fluids 
into the channel needs to be standardized possibly by using a syringe pump in 
order to have reproducible results and a precise protocol. An area of the injection 
	   	  	   	  109 
method that needs to be explored further is the time required to wait between 
removing the syringe, after injecting the solution into the channel, before the flow 
is driven by voltage. From the experiments performed in this study, it was seen 
that a length of time must be waited for the residual effects of the pressure to 
diminish in order for the voltage to successfully drive the solution down the 
channel. The time cannot be for an extended time as the particles can settle to the 
bottom of the channel and will not be moved until pressure is applied to the 
system. Once these areas of the CE system are understood, optimization and 
alterations of the buffer solution, applied voltage and injection methods can be 
made to make the system better equipped for field applications.  
Blood Separation 
 Once the separation CE system is understood and successful, and 
permission is granted, development of the blood separation system can be 
attempted ass it could not be during this study. The microchip blood separation 
technique provides a methodology that could easily be replicated and integrated 
onto a chip with the CE system (Figure 57). Recreating the techniques described 
in the paper could be a fairly simple approach with areas for success. If the 
technique was successful, integration of the two chip designs could be possible by 
using the plasma waste reservoir as the sample well for the CE system. Prior to 
integration of the systems, a test to validate that MDA remains in the plasma after 
separation would be necessary. Once proven, the blood separation portion could 
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be optimized to determine the required volume of whole blood needed to obtain 
enough plasma for an accurate reading of MDA concentration in the sample.  
 
Figure 57. Possible design for microchip combining both whole blood separation 
and MDA detection.  
Once the system has been optimized, the accuracy or limit of detection 
needs to be determined and compared to clinical values. If the limit of detection 
were too low to detect a difference between an oxidative and non-oxidative state, 
the system would be futile. The system could help by creating a standard for 
detection of MDA in relation to TBI by reducing the variances and inconsistences 
due to methodologies of sample preparation and analysis techniques. Using a 
standard procedure a baseline for normal and injured states could be created. 
Relating time, injury types, and outcomes would greatly improve clinical practice 
of treating TBIs by developing procedures based on the known outcome from a 
MDA reading. The potential to reduce TBI effects from early diagnosis would 
greatly improve the quality of life of patients globally and could change the 
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outcome of patients from unfavorable to favorable and reduce the costs of TBI 
related problems.  
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